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Objectives: This study is aimed at investigating the inhibition of chondrocyte 
phenotype loss during in vitro expansion through antagonizing the Wnt/β-catenin 
signaling pathway. The goal is to generate cartilage of a higher degree of hyaline quality 
for ACI repair.  
 
Methods: Chondrocytes were cultured in monolayer at different densities and 
exposed to a cocktail of growth factors (TFP) and the Wnt/β-catenin antagonist, 
curcumin. A control consisting of commonly-used FBS medium was included. 
Redifferentiation ability of the cells that were exposed to different expansion conditions 
was then tested through pellet culture for up to 28 days. Hyaline and fibro- cartilage 
markers like collagen II, aggrecan and collagen I respectively were analysed at the 
mRNA and protein level to assess the type of cartilage tissue formed. The level of β-
catenin was also studied to evaluate the effect of curcumin on the integral component of 
Wnt/β-catenin signaling pathway and its possible link to cartilage tissue formation. The 
possible effect of seeding density was also evaluated by expanding the cells at high and 
low seeding densities.  
 
Results: In comparison to the FBS treatment, TFP cocktail led to accelerated 
proliferation resulting in significantly increased cell yield within a shorter time. However, 
β-catenin protein and collagen I was also upregulated during this expansion phase. 
Subsequent redifferentiation of these chondrocytes later resulted in a mixed fibro- and 
 vii
hyaline cartilage tissue. Supplementation with curcumin did not significantly alter the 
proliferative effect of TFP but reversed the effects of TFP by decreasing β-catenin 
mRNA and protein, and resulted in purer hyaline cartilage formation. Higher seeding 
condition proved to be advantageous in retaining cartilage phenotype. Our results suggest 
an association between β-catenin expression and subsequent redifferentiated tissue 
quality. 
 
Significance: Addition of curcumin in conjunction with growth factor cocktail during 
monolayer expansion led to the formation of purer, more hyaline cartilage. This is 
clinically significant since current cartilage repair techniques were found to produce 
hyaline cartilage only after a few years. This could translate to a faster healing for 
patients suffering from cartilage damage. 
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LITERATURE REVIEW  
 1
 CHAPTER 1 
 
1. LITERATURE REVIEW 
 
1.1 Cartilage structure, function and repair 
 
Cartilage is the translucent and elastic connective tissue that constitutes most of 
the skeletal system during the early years of growth and development. It is a stiff yet 
flexible connective tissue found in many areas in the bodies of humans and other animals, 
including the joints between bones, the rib cage, the ear, the nose, the knee, the ankle, 
bronchial tubes and the intervertebral discs. It functions as a low-friction, wear-resistant, 
load-bearing tissue (Chen A. C. 2004). Cartilage is composed of specialized cells called 
chondrocytes that produce a large amount of extracellular matrix composed of collagen 
fibers, abundant ground substance rich in proteoglycan, and elastin fibers. Chondrocytes 
provide the essential function of maintaining cartilage homeostasis by regulating the 
balance between matrix anabolism and catabolism (Aigner, Soder et al. 2007). Unlike 
other connective tissues, cartilage does not contain blood vessels. The chondrocytes 
obtain nutrients by diffusion, helped by the pumping action generated by compression of 
the articular cartilage or flexion of the elastic cartilage. Thus, compared to other 





1.1.1 Three basic types of cartilage and their functions 
 
Cartilage can be characterized into three types; elastic, hyaline and fibrous, based 
on the difference in the relative amounts of ground substance rich in proteoglycan and 
type of collagen fibers present.  
 
Elastic cartilage is yellow-colored and is located in the epiglottis and external 
auditory canal.  Elastic cartilage is identifiable from its high type II collagen amount and 
a comprehensive network of branched elastic fibres. The chondrocytes in elastic cartilage 
are abundant and closely packed.  
 
 Hyaline cartilage is a bluish opalescent tissue (Meyer 2006) and is the most 
abundant and widely distributed cartilage type in the human body. It can be found in the 
articular cartilage of joints, trachea, bronchi, nose and epiphyseal growth plate in bones. 
It is composed of 70% water, 15% type II collagen and a similar percentage of 
proteoglycans in weight. It is segmented into superficial, middle and deep zone (Chung 
and Burdick 2008), which makes up approximately 10%, 60% and 30% of the total 
cartilage thickness respectively (Mow, Ratcliffe et al. 1992). Each zone varies in structure 
and function, with the sole resident cell type being chondrocytes. The chondrocytes are 
well-dispersed and characteristically exhibit the round or oval shape of cells often 
surrounded by lacunae, occupying only 1% of the total volume. From the superficial to 
the deep layers of the articular cartilage, the chondrocytes progressively change in shape, 
from a flattened to a rounded morphology, perhaps to provide resilience to mechanical 
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compression (Kolettas, Buluwela et al. 1995). With increasing zonal depth, the response 
of the chondrocytes in terms of their gene expression profile and protein synthesis varies 
to different stimuli, and is dependent on the position in the cartilage zone. As the zone 
deepens, the concentration of extracellular matrix (ECM) components, chondroitin 
sulphates, glycosaminoglycans and collagen becomes higher, conferring the deep zone 
with superior mechanical properties compared to the superficial zone (Chung and 
Burdick 2008). The ECM, being rich in collagen II, forms a spherical structure around the 
cell to act as a cushion when subjected to very high compressive loads. The building 
blocks of collagen are alpha chains, which undergoes multiple stages of coiling to form 
firstly, a triple helix made up of three identical intertwined polypeptide chains, then a 
tropocollagen molecule, followed by collagen fibrils with quarter stagger array. This 
architecture provides the cartilage with its tensile strength and tissue stiffness (Brower 
and Hsu 1969; Suh, Li et al. 1995), allowing frictionless joint movement by absorbing 
and transmitting applied loads across mobile surfaces (Martel-Pelletier, Boileau et al. 
2008). Another major component of the ECM is the proteoglycan (PG), consisting of 
hydrodynamically large, aggregating aggrecan with covalently linked sulfated 
glycosaminoglycans (Suh, Li et al. 1995; Frenkel and Di Cesare 1999). The PG 
components ensure high water content, thus providing osmotic properties that give 
cartilage its resistance to compressive loads (Martel-Pelletier, Boileau et al. 2008). 
 
 Fibrocartilage is present in intervertebral discs, annulus fibrosus, menisci of the 
knee joint and junctions between tendons and articular cartilage in large joints (Meyer 
2006). It consists of elliptical-shaped cells embedded in small lacunae, and between 
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dense collagen I fibre bundles lying in a random, irregular manner (Roberts, Menage et 
al. 2009). Since fibrocartilage consists of a mixed matrix midway between fibrous tissue 
and cartilage, it can withstand compression, tension and shearing forces, though to a 
lesser extent compared to hyaline cartilage (Freemont and Hoyland 2006). The 
magnitude and dynamic modulus of hyaline cartilage is 20-50 times larger than 
fibrocartilage during dynamic compression and shear testing due to differences in tissue 
stiffness (Shogo Miyata 2005).  
 
1.1.2 Autologous Chondrocyte Implantation 
 
Trauma to the knee, accidents or highly repetitive movements could lead to 
cartilage damage like tearing and formation of defects, which if left untreated, could 
possibly worsen into osteoarthritis.  However, cartilage tissue is infamous for its poor 
repair, due to the cumulative effect of non-vascularization and immobile chondrocytes 
from matrix envelopment. The world population is aging and realistically, an exponential 
rise in the numbers of patients needing cartilage-related treatments could be expected. If 
the treatment of cartilage injuries of the knee can be done in the early stages, it can 
prevent the development of osteoarthritis or the need for total knee replacement might be 
postponed or even eliminated (Brittberg, Lindahl et al. 1994). 
 
There has been many cartilage repair techniques reported to successfully repair 
the tissue damage. Periosteal grafting was used to resurface patellar defects (Niedermann, 
Boe et al. 1985), mosaicplasty (Matsusue Y 2002), was a technique where healthy 
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osteochondral cylinders were transplanted into articular cartilage defects. Another 
technique called microfracture (Steadman, Miller et al. 2003) involved marrow 
stimulation through drilling of holes to penetrate subchondral layer, and more have been 
described to result in repair of small articular cartilage lesions. 
 
Autologous chondrocyte implantation (ACI) is a technique for improving the 
repair of articular cartilage defects that are larger than 4 cm2 (Schulze-Tanzil 2009). The 
procedure was first carried out in rabbits in 1984 (Peterson L 1984) and these positive 
results formed the basis for the first human trial performed on 23 patients in 1994 
(Brittberg, Lindahl et al. 1994), where patients suffered from deep cartilage defects 
measuring 1.6 - 6.5 cm2 and experienced symptoms like knee locking, localized pain and 
swelling. ACI could be best described as a two-step process (Figure 1). In the first step, 
through arthroscopy, the position and degree of cartilage damage is evaluated, and if it 
falls within treatable range, a small cartilage biopsy weighing about 250 miligrams from 
the outer edge of supplementary medial, lateral femoral condyle or the inner edge of 
lateral femoral condyle at the intercondylar notch, will be extracted. After enzymatic 
digestion, chondrocytes released from the extracted cartilage are propagated on plastic 
flasks to produce increased cell numbers for implantation. In the second step, knee 
arthrotomy is carried out, non-viable tissues are removed, and any instability or 
biomechanical misalignment is corrected. The ex vivo expanded chondrocytes are placed 
in the defect site and covered with a periosteum stitched over the defect site for the 
purpose of containment (Brittberg, Lindahl et al. 1994). 
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After ACI, cartilage maturation develops through several phases, marked by 
initial cellular proliferation starting within the first 6 weeks, followed by a transition 
phase in the next 4 to 6 months and finally the remodeling of the extracellular matrix, 
which begins at 6 months (Gikas, Morris et al. 2009). At 1 year postoperatively, 
replacement cartilage is initially fibrocartilaginous, but there will be turnover and 
remodeling of fibrocartilaginous matrix via enzymatic degradation and synthesis of 
collagen II, indicative of a developing cartilage (Roberts, Hollander et al. 2001). At 2 
years, the ratio of collagen II to procollagen IIA is less than 2% (Roberts, Menage et al. 
2009), and 14 out of 16 patients had good to excellent results, and 11 had intact articular 
surface and hyaline appearance, with histological analysis showing chondrocyte lacunae 
and metachromatic staining comparable to native articular cartilage. Thus transplanted 
cells and periosteum were able to regenerate normal hyaline cartilage in the defect site 
(Brittberg, Lindahl et al. 1994). At 3-5 years, the ratio of collagen II to procollagen IIA, a 
collagen precursor believed to bind to growth factors in developing chondrogenic matrix 
(Zhu, Oganesian et al. 1999) has been shown to reach 30%. However, biopsies extracted 
were predominantly fibrocartilage (mostly type I or IIA procollagen), with 15% hyaline, 
17% mixed morphology, 3% fibrous. It was concluded that cartilage repair tissue 
produced following ACI takes several years to mature, since 45% were found to be of 
hyaline quality at 18 months post-ACI, while earlier time points showed only 24%. The 
presence of hyaline cartilage containing collagen II in post-ACI repair correlated with 
good to excellent clinical results (Roberts, Menage et al. 2009). It was suggested that 
with the doubling of time, the likelihood of obtaining hyaline repair cartilage is increased 
by more than 4 folds (Gikas, Morris et al. 2009). A post-operative survey carried out by 
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Sally Roberts and her team showed that 34 months after ACI, the average thickness of 
neocartilage formed is around 2.5 mm thick and only 22% is predominantly hyaline. A 
high percentage of 30% is prevalently fibrocartilaginous and half of the outcome is a mix 
of hyaline and fibrocartilaginous tissue (Roberts, McCall et al. 2003). These cartilage 
tissues might be predisposed to deterioration due to inferior mechanical loading strength 
as time passes. 
 
1.1.3 Improvements made to ACI 
 
Numerous studies have been done to augment and fine-tune the ACI technique. 
Currently there exists a third-generation ACI technique (Marlovits, Zeller et al. 2006) 
which utilizes a cell-gel mixture of collagen, HA and fibrin that solidifies very quickly, 
ensuring its location in-situ at the defect site, with reduced surgical time. Membranes and 
periosteum are not required and it has corrected defects that are larger and irregular in 
shape. Recently a variation in technique involving cells and biomaterials called Hyaff 3D 
matrix has surfaced. The Hyaff biomaterials are predominantly made up of high 
quantities of HA-rich derivatives that are conducive for chondrocyte regeneration. 
Briefly, the chondrocytes are isolated, passaged in culture on plastic dishes up to 3 weeks 
and cells were implanted at a total of 40 million cells per graft. Another product called 
Chondron uses a cell-gel mixture of collagen, HA and fibrin. It shares the same 
advantages as Hyaff-3D, except for a further improvement in its property of an even cell 
distribution in the 3-dimensional structure. Apart from delivery of implanted cells in 3D 
gelation format, seeding of chondrocytes on biomaterial membranes has also been 
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reported. Chondro Gide is a mixture of  Collagen I and III porcine-derived bilayered 
structure that enables chondrocyte adhesion due to its watertight patch, and Matrix-
assisted cell implantation (MACI) involves chondrocyte expansion on a collagen 
membrane ex-vivo before reimplantation (Getgood, Brooks et al. 2009). Good short-term 
post-operative results at 1 year for MACI have shown that the repair cartilage was 
comparable to the ACI technique (Bartlett, Skinner et al. 2005) and at 2 years, repaired 
tissue was hyaline in quality (Zheng, Willers et al. 2007), but prevalence of 
fibrocartilaginous repair tissue was also reported (Behrens, Bitter et al. 2006).   
 
With advances made on the subject of cell delivery and implantation, the 
limitation posed by extensive cell expansion should not be neglected either. Firstly, a 
prolonged period of chondrocyte expansion in vitro using animal-derived FBS in the 
conventional culture method could open up the possibility of infectious contamination 
and antigenicity for the patient involved. Preventive measures like quality control steps 
could be undertaken to ensure that cell products are free from contaminants like 
mycoplasma and fungus. However, animal serum-free culture methods are still believed 
to be better, made possible through the usage of autologous conditioned human serum 
(Tallheden, van der Lee et al. 2005; Baltzer, Moser et al. 2009; Getgood, Brooks et al. 
2009; Ho, Yang et al. 2009). Nonetheless, to obtain an amount sufficient for promoting 
cell growth, it has the disadvantage of requiring a large intravenous volume of blood to 




Secondly, chondrocytes fall under the category of specialized, terminally-
differentiated mature cells which are slow-dividing in their native environment. When 
isolated and cultured under standard culture medium, the proliferation rate has been 
observed to be low. Adult chondrocytes have limited mitotic potential (Evans and 
Georgescu 1983; Martin and Buckwalter 2001) and in due course would enter a state of 
replicative senescence. This state is marked by failure to proliferate (Hayflick 1965) and 
can occur both in vivo and in vitro (Martin and Buckwalter 2002; Martin and Buckwalter 
2003). Efforts have been made in the area of telomerase manipulation by transducing 
chondrocytes with retroviral construct to lengthen the telomeres and lead to a 
subsequently increased lifespan (Piera-Velazquez, Jimenez et al. 2002). 
 
Thirdly, therapeutic applications such as engineering of cartilage transplants 
requires the prior amplification of chondrocytes in monolayer culture before they can be 
transplanted into 3D matrix to generate potentially cartilage-like tissue. A serious side 
effect arising from monolayer expansion is dedifferentiation (Holtzer, Abbott et al. 1960; 
Abbott and Holtzer 1966; Von der Mark 1986), a loss of the differentiated phenotype. 
Cultured chondrocytes tend to dedifferentiate into fibroblasts (Thirion and Berenbaum 
2004) or become fibroblastic in appearance (Aulthouse, Beck et al. 1989; Bonaventure, 
Kadhom et al. 1994). The conversion from chondrocyte to fibroblast phenotype can be 
detected based on a switch from the synthesis of type II collagen to type I, III, and from a 
higher molecular weight (MW)  aggrecan to low MW biglycan and decorin (Thirion and 
Berenbaum 2004). The subsequent culturing of chondrocytes in 3D with chondrogenic 
medium usually provides sufficient stimuli for cells to redifferentiate. However, when the 
dedifferentiation is irreversible, cells will fail to recapitulate their chondrogenic ability 
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and instead synthesize a fibroblastic ECM. Irreversible dedifferentiation have been 
connected to the formation of fibrocartilaginous repair tissue, an unwanted yet 
frequently-faced problem with in vivo ACI tissue engineered constructs (Nehrer, Spector 
et al. 1999; Peterson, Brittberg et al. 2002). Characterized by a large proportion of 
collagen I in the matrix and coupled with a disorganized structure, the biomechanical 
properties of fibrocartilage is inferior to healthy articular cartilage, and thus longevity of 
implanted constructs could be compromised when placed in rigorous weight loading 
environment (Mitchell and Shepard 1976; Buckwalter and Mankin 1998). In an attempt 
to improve quality of tissue engineered cartilage with culture-expanded chondrocytes, 
various expansion media supplemented with growth factors were recently developed 
(Jakob, Demarteau et al. 2001; Mandl, van der Veen et al. 2002)  
 
1.2 Role of growth factors in chondrocyte regulation 
 
 Growth factors are essential polypeptides for the production and maintenance of 
an ECM capable of protecting the cartilage joint against damage incurred by repetitive 
movement or injury (Martel-Pelletier, Boileau et al. 2008). The use of growth factors 
during cell division have been proposed as a promising method to increase cell numbers 
obtained from small biopsies, especially for cell types with limited proliferative capacity 
(Simmons and Haylock 1995). Usage of growth factors like platelet-derived growth factor 
(PDGF) (Kieswetter, Schwartz et al. 1997), insulin-like growth factor (IGF) (Fukumoto, 
Sperling et al. 2003), transforming growth factor (TGF) (Rosier, O'Keefe et al. 1989; 
Vivien, Galera et al. 1990; Grimaud, Heymann et al. 2002), bone morphogenetic protein 
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(BMP) (Park, Sugimoto et al. 2005), fibroblast growth factor (FGF) (Martin, Vunjak-
Novakovic et al. 1999; Takahashi, Ogasawara et al. 2005) during monolayer culture has 
been found to be advantageous to the proliferation of human cells (Guerne, Blanco et al. 
1995). Growth factors have both been applied sequentially and simultaneously.  
Sequential application of growth factors TGFß1, FGF2 and IGF for 28 days promotes 
chondrocytes to first dedifferentiate into a proliferative state and then redifferentiate and 
regenerate full tissues (Pei, Seidel et al. 2002). Simultaneous combinations of growth 
factors was narrowed down to TGFβ1, βFGF, PDGF-ββ and EGF (Jakob, Demarteau et 
al. 2001) and a mixture of TGFB1, FGF and PDGF-ββ was found to improve cell 
proliferation for 5 successive passages (Barbero, Ploegert et al. 2003). It was found that 
synergized application of growth factors instead of individual application of growth 
factors is better since it led to a 24-fold increase in collagen II to collagen I ratio that 
denoted the improved redifferentiation ability of FGF/TGFβ1 expanded cells. The 
improved chondrogenesis could be attributed to the combined effect of the individual 
cytokines (Brandl, Angele et al. 2009).  
 
TGFβ1 is a member of the TGFβ superfamily, and is a secreted homodimeric 
pleiotropic protein that controls various aspects of cellular development like proliferation, 
differentiation, ECM synthesis, migration, cell death (Reddi 2006), and is the most 
prominent TGFβ isoform in cartilage, compared to TGFβ2 and TGFβ3 (Yoon and Fisher 
2006). TGFβ controls the direction of chondrocyte maturational process, be it suppression 
or acceleration (Drissi, Zuscik et al. 2005), and also prevents the development of 
differentiated chondrocytes into hypertrophy (Yang, Chen et al. 2001)). Their mode of 
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action begins when members of the TGFβ family bind to a heteromeric receptor complex 
on cell surface and activate an intracellular signal tranducing the SMAD complex 
involved as intracellular substrate for TGFβ signaling. The receptor complex initiating 
TGFβ response consists of type 2 and type 1 TGFβ receptors. These receptors are 
transmembrane serine/threonine protein kinases which phosphorylate cytosolic SMADs 2 
and 3, resulting in conformational change and permitting interaction with common 
SMAD, initiating nuclear translocation. Once in the nucleus, they act in collaboration 
with sequence-specific transcription coactive transcription factors (TFs) to initiate and 
regulate gene expression.  
 
PDGF-ββ, a 30kDa disulfide-linked heterodimer glycoprotein, can be found at 
platelet migration sites. It functions as a chemo-atttractant with stimulatory effects on 
morphogens and fibroblasts during healing. It has also been found to exert an impact on 
mesenchymal stem cell (MSC) differentiation, increase matrix production and halts 
chondrocytes from undergoing terminal differentiation (Getgood, Brooks et al. 2009). 
 
βFGF is a well-known survival factor for cells organized in 3-dimensional 
structures (Martin, Vunjak-Novakovic et al. 1999), and can be mitogenic for cells of 
mesodermal origin. Similar to PDFG, it is a chemo-attractant for endothelial cells, and 
inhibits chondrocyte terminal differentiation (Getgood, Brooks et al. 2009). It functions 
in articular cartilage homeostasis through aiding the synthesis and degradation of 
proteoglycans and collagen II. Depending on its concentration in articular cartilage, it can 
be anabolic or catabolic. Its anabolic strength has been shown to regenerate damaged 
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articular cartilage tissue (Jingushi, Shida et al. 2006). βFGF is known to promote 
redifferentiation of chondrocytes, and enhances expression of Sox9, a master regulator 
gene for collagen II, via the mitogen-activated protein kinase (MAP kinase) pathway 
(Schulze-Tanzil, Mobasheri et al. 2004). 
 
1.2.1 Growth factors influence chondrocyte phenotype 
  
The use of anabolic growth factors has been shown to have an impact on the 
dedifferentiation and subsequent redifferentiation of adult human articular chondrocytes 
(Martin, Vunjak-Novakovic et al. 1999; Jakob, Demarteau et al. 2001; Darling and 
Athanasiou 2005). FGF-2 was found to suppress the formation of thick F-actin structures 
during monolayer expansion and this enabled the chondrocytes to redifferentiate and 
express their differentiated phenotype (Martin, Vunjak-Novakovic et al. 1999). The 
utilization of growth factors has also been suggested as de-differentiation delay tactics to 
preserve the chondrogenic potential of dedifferentiated cells. Shakibaei et al reported that 
the addition of growth factor into the expansion medium delayed the loss of 
redifferentiation capability and apoptosis up till passage 7 (Shakibaei, Seifarth et al. 
2006). The presence of growth factors have been suggested to influence cell potential to 
re-differentiate and respond to regulatory molecules upon transfer into 3D environment 
(Jakob, Demarteau et al. 2001), culminating in the enhancement of chondrogenesis and 
cartilaginous formation in vitro (Barbero, Ploegert et al. 2003). Cells exposed to a 
mixture of TGFB1, FGF and PDGF-ββ (TFP) treatment during monolayer expansion 
were also found to possess increased post-expansion chondrogenic capacity, evidenced 
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from the GAG and collagen II production (Barbero, Grogan et al. 2004).  However, the 
promising results from Barberos’ publications did not further investigate the phenotype 
status of the derived cartilage.  
 
1.2.2 Phenotype loss connected to irreversible dedifferentiation 
 
Dedifferentiation can be identified by physical and biochemical alterations 
occurring at multiple levels of chondrocyte synthesis profiles; including cytoskeletal 
proteins, surface receptors and ECM (Schulze-Tanzil 2009). Morphologically, 
chondrocytes change from a rounded to a flattened and fibroblastic shape. The 
morphologic change in which the cell diameter becomes larger in monolayer culture 
(Sasazaki, Seedhom et al. 2008) could be connected to changes in cytoskeletal assembly 
which in turn affects percentage of ECM components. The expression of cell surface 
markers associated with MSCs like CD10, 90, 105, 166 could be observed, together with 
the detectable metabolic shift (Diaz-Romero, Gaillard et al. 2005) where cells have been 
known to cease the production of collagen II, aggrecan and instead produce collagen I, 
with reduced proteoglycan synthesis ((Benya and Shaffer 1982; Darling and Athanasiou 
2005).  
 
Extensive dedifferentiation through successive passaging has been shown to result 
in its irreversibility. Accio et al (Dell'Accio, De Bari et al. 2001) published a finding that 
at passage 5 onwards, cells did not produce chondrocyte-specific ECM when 
redifferentiated, and remained fibroblast-like. The loss was not limited to a 
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morphological difference. It extended into influencing the ECM composition for a certain 
period of time. Zauke et al (Zaucke, Dinser et al. 2001) reported that cells which have 
undergone dedifferentiation and started to produce collagen I in monolayer, would 
continue to do so for an additional 2 weeks despite being transferred into an environment 
conducive for redifferentiation. 
 
Chondrocytes are known to prefer cell-cell interaction and retain phenotype better 
in 3D culture, whereas attachment to 2D culture plastic alters the phenotype, promoting a 
more fibrochondrocytic phenotype (Darling and Athanasiou 2005). The seeding density 
for monolayer expansion has been found to influence the degree of dedifferentiation. It 
was postulated that seeding could affect intercellular communications, either via cell to 
cell contact or secreted factors, in addition to influencing chondrocyte ability to 
incorporate newly-synthesized collagen and proteoglycans into the extracellular matrix 
(Watt 1988). Since the early 1960s, it was shown that dedifferentiation is enhanced with 
low seeding densities (Thirion and Berenbaum 2004). Therefore high seeding density 
(30000 cells/cm2 to 50000 cells/cm2) was used to prevent dedfferentiation (De Ceuninck, 
Lesur et al. 2004). Several mechanisms have been proposed by which the lower seeding 
density resulted in more dedifferentiation. Firstly, cells seeded at lower density must 
undergo more population doubling to achieve desirable number and furthermore, cell-cell 
contact inhibition will be less. Secreted factors by chondrocytes that condition the 
medium can have a role in stabilizing phenotype. These factors will be of lower 
concentration in low seeding density cultures. Another mechanism of dedifferentiation 
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could be through the difference in cell shape during monolayer culture, since cellular 
function is influenced by microfilament organization.  
 
Recently it has been debatable whether a high or low seeding density is better in 
reducing dedifferentiation rate, as newer studies carried out in this decade have 
concluded otherwise. It was shown that in comparing four different seeding densities of 
3500, 7500, 15000 and 30000 cells/cm2 during monolayer culture, the lowest density of 
3500 cells/cm2 resulted in a better outcome measured by chondrogenic potential in 
addition to increased chondrocyte numbers, and a preserved redifferentiation capacity of 
chondrocytes was observed (Mandl, van der Veen et al. 2004) 
 
1.3 Wnt/β-catenin pathway 
 
1.3.1 Association of Wnt/β-catenin pathway with chondrocyte dedifferentiation  
 
Dedifferentiation has been linked to Wnt/β-catenin signaling pathway (Hwang, 
Ryu et al. 2004). The Wnt family of morphogenic glycoproteins exert a concentration-
dependent effect on cell fate (Neumann and Cohen 1997), and are involved in the 
regulation of multiple cellular activities, including bone formation and remodeling during 
growth and development and in the postnatal state. Wnt 7a was observed to have caused 
the inhibition of collagen II and the onset of collagen I expression in chondrocytes, the 
typical symptoms of chondrocyte dedifferentiation. Wnt 7a caused the suppression of 
collagen II by stimulating transcriptional activity of β-catenin-Tcf/Lef complex and 
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inhibits chondrogenesis by stabilizing cell-cell adhesion through sustained expression of 
β-catenin (Hwang, Ryu et al. 2004). Overexpression of dominant negative Tcf-4 led to 
the inhibiton of β-catenin transcriptional activity and rescued the suppression of collagen 
II induced by Wnt/β-catenin activation (Hwang, Ryu et al. 2004). β-catenin is an effector 
in the Wnt signaling pathway (Roose, Huls et al. 1999). It can be found in the cytosol and 
nucleus. Cytosolic β-catenin has two forms, an unphosphorylated β-catenin that can 
undergo nuclear translocation and a phosphorylated β-catenin that is targeted for 
proteosomal degradation (Wang, Chen et al. 2006; Freudlsperger, Greten et al. 2008). 
Accumulation of β-catenin in the cytoplasm results in translocation to the nucleus where 
it will bind to transcription factors like LEF/TCF to generate transcriptionally active 
complex that targets specific genes such as cyclin D1 and CD44 (Barker and Clevers 
2000). Regulation of β-catenin is essential to ensure proper development and 
differentiation of many tissues (Barker and Clevers 2000). In the Wnt signaling pathway, 
β-catenin is positively regulated by proteins like TC1 (Jung, Bang et al. 2006) and CKIε 
(Swiatek, Tsai et al. 2004) which enhances the signaling activity, and is negatively 
regulated by APC protein, GSK3b and axin. This happens through constitutive 
phosphorylation by GSK3ß at the β-catenin regulatory amino terminal located at the 
serine/threonine residues, which marks β-catenin for sequestration, ubiquitination in the 
cytoplasm, and the subsequent degradation by proteosomes (Roose, Huls et al. 1999). 
Works by these groups have shown that the transcriptional activity of β-catenin 




 1.3.2 Curcumin as a Wnt/ β-catenin antagonist 
 
Signaling pathways can be blocked by antagonists that obstruct agonist-mediated 
responses. Antagonists inhibit extracellular signaling molecules by acting as binding 
proteins that block signaling proteins’ ability to bind surface receptors and thus inhibit 
the mediated response (Yoon and Fisher 2006). Wnts are regulated by antagonists that 
interact at multiple points in the signaling pathway (Corr 2008), and can be categorized 
into extracellular and intracellular mechanisms. Examples of extracellular antagonists to 
the canonical Wnt signaling pathway are secreted frizzled-related proteins (sFRPs) and 
Dickkopf.  sFRP exert their inhibitory effect by binding to the Wnt ligands, preventing 
them from binding to the receptors, LRP-5 and -6 receptors. Dickkopf exert their action 
by directly binding to the LRP-5 and -6 receptors (Bafico, Liu et al. 2001; Mao, Wu et al. 
2001; Semenov, Tamai et al. 2001; Kawano and Kypta 2003). Intracellular antagonists 
act through the disruption of β-catenin signaling and can be achieved by increasing 
degradation of β-catenin with overexpression of GSK3β (He, Saint-Jeannet et al. 1995), 
or blocking Wnt transcriptional activity in the nucleus by expressing dominant negative 
forms of TCF (Molenaar, van de Wetering et al. 1996). Increasingly, small molecules 
that can inhibit Wnt signaling by targeting various components of the pathway have been 
reported (Meijer, Flajolet et al. 2004; Barker and Clevers 2006). 
 
Curcumin, chemically labeled as diferuloylmethane, is formulated as C21H20O6 
and has a small molar mass of 368.38 g/mol. It is a polyphenol that is derived from the 
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plant Curcuma Longa, a member of the ginger Zingiberaceae family and could be found 
in abundance in tropical countries (Sa and Das 2008). It is the main curcuminoid of the 
popular Indian spice turmeric, responsible for the yellow color and bioactivity of turmeric 
(Aggarwal and Sung 2009). Curcumin can exist in at least two tautomeric forms, keto and 
enol. The enol form has been used historically as a component of Indian Ayurvedic 
medicine treat various types of health problems (Aggarwal and Sung 2009). In vitro and 
animal studies have suggested a wide range of potential therapeutic or preventive effects 
associated with curcumin, and a few clinical trials have concluded that curcumin does not 
have side-effects and is a promising drug for many diseases associated with the aging 
process. As of 2008, numerous clinical trials in humans were underway, studying the 
effect of curcumin on numerous diseases including multiple myeloma, pancreatic cancer, 
myelodysplastic syndromes, colon cancer, psoriasis, and Alzheimer's disease (Hatcher, 
Planalp et al. 2008). The wide-ranging effects of curcumin could possibly be explained 
by its pleitropic activity whereby its mechanisms are found to be diverse and appears to 
involve a combination of cell signaling pathways at multiple levels which influences its 
regulation of gene transcriptional processes. It inhibits activator protein API which is 
involved in the regulation of cell proliferation and apoptosis. It also inhibits NFkb, 
known to be involved in pro-survival and apoptotic pathways (Salvioli, Sikora et al. 
2007), through inhibition of IKK and AKT activation (Aggarwal, Ichikawa et al. 2006). 
Curcumin is widely known for its anti-carcinogenic effect through the suppression of 
wanton cellular proliferation (Mehta, Pantazis et al. 1997). Its anti-proliferative effect has 
been observed on many cell types, and a possible mechanism that has been pointed out 
was through apoptosis (Freudlsperger, Greten et al. 2008). 
 20
 Curcumin derivatives were found to be antagonistic to the Wnt/β-catenin 
pathway.  The antagonistic effect of curcumin on the Wnt/β-catenin pathway has been 
suggested to occur intracellularly, at the nucleus level, by decreased nuclear translocation 
of β-catenin and Tcf-4. Inhibiting the association of β-catenin with Tcf-4 resulted in 
blocking the transcription of β-catenin responsive genes (Park, Hahm et al. 2005). 
Inhibitory effects of curcumin derivatives have also been reported through its effect on 
transcriptional coactivator p300 (Ryu, Cho et al. 2008). Curcumin exerted induction of 
cell cycle arrest and apoptosis was suggested to occur through the caspase-3-mediated β-
catenin cleavage (Jaiswal, Marlow et al. 2002; Ohori, Yamakoshi et al. 2006; Prasad, 
Rath et al. 2009). Curcumin’s anti-proliferative effects could have also been exerted 
through inhibiting AP-1, which is involved in the regulation of cellular proliferation of 
many cell types (Salvioli, Sikora et al. 2007). This in turn could affect chondrogenesis 
since AP-1 activation has a role in regulating Wnt pathway (Tufan, Daumer et al. 2002). 
 
We hypothesized that preventing the loss of chondrocyte phenotype during in 
vitro expansion through usage of curcumin, a Wnt/β-catenin signaling pathway 
antagonist, might generate cartilage with higher degree of hyaline quality. 
 
Our aim in this project is to: 1) investigate the effect of growth factors-
supplementation on the proliferation and phenotype of chondrocytes in monolayer 
expansion; 2) examine the effect of targeting Wnt/β-catenin signaling pathway through 
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the use of an antagonist, curcumin, during monolayer expansion; and 3) investigating the 














2. MATERIALS AND METHODS 
 
Unless otherwise stated, all reagents and chemicals used in this study were 
obtained from Sigma Incorporation (St Louis, MO). Dulbecco’s Eagle’s medium low-
glucose (DMEM-LG) was obtained from Gibco BRL Incorporation (Grand Islands, NY). 
All lab ware consumables were purchased from Becton-Dickinson (Franklin Lakes, NJ) 
 
2.1 Cell harvest and monolayer culture of chondrocytes  
 
Cartilage samples are obtained from donors diagnosed with symptomatic 
osteoarthritis who have failed to respond to medical therapy, have progressive 
impairment of daily living activities and are undergoing total knee replacement (TKR) 
(mean age 69, range 57-91).  The total sample size for histological analysis is 12 (n = 9; 
3[high seeding density], 3[low], 3[high & low]). Consent was obtained from donors and 
performed with the approval of the hospital Institutional Review Board (DSRB D00814). 
Upon collection from the operating theatre, the tissue was transferred in a sterile manner 
into a container filled with saline. The sample was washed thrice with Phosphate 
Buffered Saline (PBS) to remove fats, blood and small pieces of bone. Macroscopically 
healthy-looking cartilage without fibrillation, blood and lesions was excised.  
 
Briefly, the excised cartilage was washed twice with PBS before they were 
minced with scalpel and surgical scissors into fine cubes, digested with 0.25% trypsin 
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(TrypLE) for 45 minutes, centrifuged to remove the trypsin, and subjected to 0.25% 
collagenase for overnight at 37°C on a shaker. After 22 hours, an addition of an equal 
volume of the culture medium was added, mixed and put through a 40 μm strainer to 
separate out the tissue debris consisting of undigested cartilage pieces. Cells were 
centrifuged at 370g for 5 minutes, and the resulting cell pellet was washed twice, cell 
number counted with hemacytometer, and seeded at a concentration of 2667 or 667 
cells/cm2 (n=6 for each seeding density). Henceforth the seeding densities of 2667 and 
667 cells/cm2 will be referred to as high and low seeding density respectively. 
 
The chondrocytes were cultured in the following medium,  
(a) FBS medium (LG-DMEM + 10% FBS + P/S + Glu),  
(b) TFP medium (FBS medium + 1 ng/ml TGFβ1, 5 ng/ml βFGF and 5 ng/ml PDGF-
BB),  
(c) TFPCu medium (FBS medium + 1 ng/ml TGFβ1, 5 ng/ml βFGF and 5 ng/ml 
PDGF-BB, plus 5 μM curcumin solubilised in DMSO).  
 
 TGFβ1 (Cat no. 240-B) is from R&D Systems, βFGF (Cat. No: 13256-029) from 
Invitrogen, PDGF-ββ (Cat No: 220-BB) from R&D. The cells were left untouched for 4 
days, after which unattached cells were subsequently discarded, while adherent cells were 
further cultured, with media changed every 3 days. When the cells reached 85-90% 
confluence, the cells were washed twice with PBS, detached by adding 5 ml of 0.25% 
trypsin for 5 minutes, underwent centrifugation, cell-counted and grown in pellet culture.  
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 Cells were seeded at both densities for monolayer analysis of RNA (conventional 
and real time) and only high density for monolayer analysis of protein 
(immunohistochemistry) due to shortage of cells. The cell yield after cartilage digestion 
is low. 
 
2.2 Proliferation detection methods  
 
2.2.1 MTS assay 
 
 Cells were seeded at 667 and 2667 cells/cm2 in 96-well plates. At time points of 
3, 6 and 9 days, MTS assay (Cell Titer G3580, Promega) was carried out. Briefly, the 
medium was discarded, the cells were washed once with PBS, and MTS (317 μg/ml) was 
added, and left to incubate at 37ºC for 1 hour, after which the reaction was quenched with 
25 μl of 10% SDS following manufacturer’s instructions. Absorbance at wavelength 490 
nm with 630 nm as reference wavelength was read using a spectrophotometer (Tecan 
Infinite m200). 
 
2.2.2 Population doubling (PD) 
 
At 85-90% confluency, chondrocytes were trypsinized. PD count and PD time 
was obtained through calculation involving net cell yield and culture time. The online 





2.3 Chondrogenic differentiation 
 
Chondrogenic differentiation of the cells was induced through aggregate culture, 
under conditions described previously (Johnstone, Hering et al. 1998). Briefly, aliquots 
of 2.5x105 cells were centrifuged at 1000 rpm for 5 minutes in 15 ml polypropylene 
conical tubes to form pellets. The cell pellets were cultured in medium containing high 
glucose DMEM supplemented with 4 mM proline (Sigma), 50 µg/ml ascorbic acid 
(Sigma), 1% ITS-Premix (BD, Franklin Lakes, NJ), 1mM sodium pyruvate and 0.1µM 
dexamethasone (Sigma), up to 28 days in the presence or absence of 10 ng/ml of TGF-β3 
(Cat no: 243-B3). Media was changed every 3 days.  
 
2.4 Pellet processing 
 
For tissue processing, the aggregates were washed twice with PBS before being 
fixed overnight in 10% neutral buffered formalin, after which it underwent successive 
dehydration step of 15 minutes of 70% Alcohol (twice), 80% alcohol (twice), 95% 
alcohol (twice), 3 minutes eosin staining to enable visualization, 100% alcohol (twice), 
xylene (twice), paraffin (twice) and finally embedded in paraffin. Sections of 5 µm 
thickness were cut using the microtome and collected on superfrost-coated slides, dried 




2.5 Histological staining 
 
2.5.1 Alcian Blue staining 
 
For Alcian blue staining, the tissue sections were de-paraffinized in xylene (twice, 
5 minutes each) and xylene:alcohol 1:1 (2 minutes), 100% alcohol (2 minutes), 95% 
alcohol (2 minutes), 70% alcohol (2 minutes), water wash for 2 minutes before 
immersion into 0.5% alcian blue dissolved in 0.1 M hydrochloric acid for 30 minutes, 
washed with deionised water for 1 minute, and counterstained with nuclear fast red for 5 
minutes. After that, water wash for 5 seconds, dehydration through 95% alcohol (twice, 5 
minutes each), 100% alcohol (twice, 5 minutes each), xylene (thrice, 5 minutes each), 
before coverslipped. 
 
2.5.2 Immunohistochemistry of collagen I and collagen II 
 
For immunohistochemistry, slides were similarly deparaffinized, endogenous 
peroxidase was blocked with Hydrogen Peroxide Block before a pepsin treatment for 20 
minutes. Monoclonal antibodies of collagen type I (Sigma, C2456) and collagen type II 
(Chemicon International, Inc.,Temecula, CA.) of dilution factor 1:500 and collagen type 
X (Quartett, Berlin, Germany) of dilution factor 1:25 was applied on separate slides for 
an hour followed by incubation with biotinylated goat anti-mouse (Lab Vision 
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Corporation, Fremont, CA.) for 30 minutes. Streptavidin Peroxidase was added for 45 
minutes and 3,3' Diaminutesobenzidine was used as a chromogenic agent and 
counterstaining was done with Gill’s hematoxylin. The slides were dehydrated similarly 
to the abovementioned procedure, before coverslipped 
 
2.5.3 Immunofluorescence staining on well plates 
 
Cell cultures adhered on the tissue culture plates were fixed with 4% 
paraformaldehyde (Sigma) for 20 minutes at room temperature. After washing with PBS, 
cells were permeabilised using 0.2% (v/v) Triton X-100 (Biorad, Hercules,CA) in PBS. 
2% bovine serum albumin (BSA) diluted in PBS was used as the diluent for subsequent 
reagents and antibodies. Cells were blocked with 5% (v/v) goat serum diluted in 2% 
BSA/PBS for 1 hour at room temperature prior to incubation with mouse monoclonal 
antibody anti-collagen II (MAB8887, Chemicon), collagen I (C2456, Sigma) and β-
catenin (SC-7963, Santa Cruz,) at a dilution factor of 1:200 with 2% BSA/PBS to a final 
concentration of 0.4 μg/ml. Isotype mouse IgG was used as negative control at a dilution 
factor of 1:1000 to the same final concentration. After incubation for 3 hours at room 
temperature, the samples were washed twice with 0.05% (v/v) Tween 20 (Biorad) diluted 
in PBS and once with PBS, followed by incubation with 10 μg/ml (1:500) Alexa Fluor 
488 anti-mouse IgG (Invitrogen, Oregon, USA) in the dark for 2 hours. After washing 
with PBS, the samples were mounted with Slow Fade Gold antifade reagent containing 




2.6 RNA extraction and cDNA synthesis 
 
Freshly collected samples were first washed with PBS before digestion with 
0.25% collagenase at 37°C for 3 hours. Cells were collected by centrifugation and RNA 
was extracted using the RNeasy Mini Kit (Qiagen, Chatsworth, CA). Cells were 
disrupted and fully dissolved by incubation with RLT lysis buffer (Qiagen) containing 
highly-denaturing guanidine-thiocyanate, with 350ul of the solution, for 2 minutes at 
room temperature, before an equal volume addition of 70% alcohol to provide 
appropriate binding conditions following the manufacturer’s instructions, and transfer 
into the spin columns provided which are lined with silica-based membrane. Total RNA 
binds to the membrane and centrifugation at 13000 rpm for 1 minute was carried out, 
after which the supernatant was removed, 700 μl of RW1 buffer was added to wash, 
centrifuged, and the steps repeated, but with two washes of 500 μl RPE buffer, to remove 
contaminants. Finally 30 μl of RNase-free water was added and the tube spun at 14000 
rpm for 1 minute. The eluant containing the total RNA is collected, placed on ice, and the 
RNA amount quantitated using Nanodrop (Nanodrop Technologies, Wilmington, DE). 
cDNA was generated from 200 ng of total RNA using iScriptTM cDNA synthesis kit 
(Biorad, Hercules, CA) at 25°C for 5 minutes, 42°C for 30 minutes, and 85°C for 5 
minutes. 115 ng of RNA was used for β-catenin and β-actin reactions, after which l μl 




2.7 Quantitative real time PCR analysis 
 
Real-time PCR is used for quantitative analysis of target gene expression, through 
amplification for cDNA samples. Power SYBR green PCR Master Mix system (Applied 
Biosystems, Foster City, Ca) was used on Applied Biosystems 7500 Real-time PCR and 
was performed using the SYBR green system. Genes of interest were normalized to 
reference gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The level of target 
gene expression was calculated as 2-ddCt. Primer sequences and their expected product 
size are listed in Table 1. 
 
2.8 Conventional Polymerase Chain Reaction 
 
Conventional PCR was performed using PCR 2720 thermal cycler (Applied 
Biosystems). β-catenin were amplified for 35 cycles at 95ºC for 3 minutes, 35 cycles of 
95ºC for 30 seconds, 55ºC for 45 seconds, 72ºC for 1 minute, followed by 72ºC for 10 
minutes. β-actin was used as the house-keeping gene to normalize PCR reactions. 
Reactions were run under the same conditions as β-catenin except for the annealing 
temperature which is at 60ºC for 45 seconds. Electrophoresis of the amplified products 
was run on 1% agarose gel. Products were subsequently visualized using UV 
transilluminator (Wealtec) and AlphaDigiDocTM RT. PCR primers, annealing 
temperature, primer sequences and their expected product size are listed in Table 2.  
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2.9 Statistical Analysis   
 
Statistical analysis was calculated using one-way ANOVA from the website 
http://www.danielsoper.com/statcalc/calc43.aspx.  Data were presented as the mean ± 
standard deviation (SD), with the level of significance set at p < 0.05. All quantitative 

















3.1 Observations of chondrocytes expanded under 3 conditions in monolayer  
 
3.1.1 Morphology and growth kinetics of chondrocytes 
 
The initial response of the isolated chondrocytes when exposed to the three 
expansion conditions (see section 2.1) was noted. The morphological appearance was 
captured by phase-contrast micrographs and assayed for differences in growth kinetics. 
Cells grown in the FBS medium took an average of 3 days to attach while the growth 
factor TFP cocktail greatly shortened the time for attachment to one day. Fewer cells 
were observed to attach on Day 1 when curcumin was introduced into the TFP cocktail, 
and cells under TFP treatment were visually observed to multiply the fastest (Figure 2). 
MTS assay showed a significantly higher cell number attained by TFP treatment 
compared to the FBS or TFPCu medium. Significance was reached earlier at day 6 and 
maintained up to day 9 when the cells were seeded at higher seeding density (Figure 3A). 
When cells were seeded at a lower density, the cells expanded at a slower rate initially 
and significant increase was detected on day 9, again with TFP-treated cells expanding at 
a significantly higher rate (Figure 3B). 
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Upon near confluency, the cell yield from chondrocytes treated with TFP is 
increased to 4-5.9 million for TFP, and 3.3-5.1 million for TFPCu treatment. The 
monolayer expansion period is noticeably shortened to about 10.6-15 days, compared to 
14.5-17.3 days under FBS treatment (Table 3). Population doubling upon near confluency 
(Figure 4) showed that the rate of population doubling of cells in FBS medium was 
significantly halved upon TFP and TFPCu addition, from an average of 6.1 days (FBS) to 
2.27 (TFP) and 2.77 (TFPCu) days at high seeding density. At lower seeding, the 
population doubling time was reduced slightly across all treatments, with 4.7 days (FBS) 
to 2.22 and 2.63 for TFP and TFPCu treatments respectively. Chondrocytes cultured in 
the basal medium adopted a flatter, rounded physical characteristic, while cells exhibited 




Figure 1: A graphic representation of the 2-step procedure involved in ACI. 
 
A small biopsy taken from a non-weight bearing cartilage area were cultured and 
expanded in flasks before implantation back into the defect site. The picture is 








Figure 2: Micrographs of chondrocytes exposed to treatments of FBS, TFP and 
TFPCu 
 
Chondrocytes were cultured in 75 cm3 flasks under 3 different conditions (FBS, TFP-
supplemented, TFPCu supplemented), and phase-contrast pictures were taken on days 9 
and 14. Magnification is taken at 40x. 
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Figure 3. Proliferation rate of chondrocytes at high and low densities in monolayer 
culture  
 
Chondrocytes were seeded at high (A) and low (B) densities in monolayer culture under 
FBS, TFP and TFPCu treatments. On day 3, 6 and 9, cells were assayed with MTS 
reagent for cell proliferation. Data were averaged from at least 3 independent 
experiments using cells from 6 donors and expressed as mean ± SD. * p<0.05, 



















Figure 4: Population doubling rates of expanded chondrocytes in monolayer 
 
Chondrocytes were grown in monolayer under low and high densities and subjected to 
FBS, TFP and TFPCu treatments. Upon confluence, the total number of chondrocytes 
obtained was counted using a haemocytometer, and the population doubling was 
calculated and tabulated. Data were averaged from at least 3 independent experiments 








Table 3: Monolayer cell yield and culture period. 
 
The cell culture period taken by P0 chondrocytes to reach near confluency and the cell 
yield during monolayer expansion were calculated. Data were averaged from 6 
independent experiments and expressed as mean ± SD 
 39
 3.1.2 Expression of β-catenin during monolayer expansion    
 
To investigate the possible effect of the different expansion conditions on β-
catenin expression levels, conventional PCR was carried out on chondrocytes expanded 
for 5, 8, 11 and 14 days (Figure 5).  At lower seeding density, β-catenin expression was 
detectable from day 11 for both FBS and TFP treated cells, with levels of ß-catenin 
increased with time (Figure 5A, B). In TFPCu treated cells, β-catenin was only detectable 
on day 14, at a markedly lower level. 
 
 At higher seeding density there is an overall delay in the expression of β-catenin 
compared to cells seeded at lower seeding density (Figure 5). Interestingly, expression 
was not detectable in the FBS sample at day 11, compared to those in the TFP-treated 
samples at the same time point.  Even at day 14, expression of β-catenin is at a lower 
level in the FBS sample than that in the TFP samples.  The levels were uniformly 
upregulated in the majority of samples at day 11 upon growth factor addition of TFP, 
with high seeding density exhibiting a reduced expression. Notably, under the curcumin 
supplemented TFP conditions, expression of ß-catenin at day 11 and 14 was hardly 
detectable under low seeding, and was undetectable when the seeding density was 
increased to high density. Quantitated β-catenin levels at both seeding densities (Figure 
5B and 5C) clearly showed the reduction in β-catenin levels at higher seeding and in the 
presence of curcumin. 
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Immunohistochemical staining for the detection of ß-catenin proteins (Figure 5D) 
showed detectable expression of β-catenin protein only in the TFP-treated samples when 
seeded at high density, detectable as early as day 7 (data not shown). A correlation 
between β-catenin mRNA and protein levels showed that TFP usage resulted in the 
upregulation of the ubiquitious protein β-catenin, and that curcumin added under similar 
culture conditions inhibited the expression of β-catenin levels caused by TFP and the 



























































Figure 5: Expression of β-catenin in monolayer expanded chondrocytes  
 
Chondrocytes were expanded under monolayer conditions under FBS, TFP and TFPCu 
treatments under high and low seeding densities. RNA samples were collected on days 5, 
8, 11 and 14 for conventional PCR analysis of β-catenin expression (A). Image is 
representative of 3 experiments. Quantification of β-catenin with cells seeded at low (B) 
and high (C) densities. The band sizes of β-catenin obtained from conventional PCR were 
quantitated and normalised against endogenous β-actin. Chondrocytes cultured for 14 
days at high seeding density were stained for β-catenin protein (D) (green fluorescence). 
Samples were counterstained for DAPI (blue). Magnification is taken at 40x. 
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 3.1.3 Expression of type I collagen during monolayer expansion  
  
 Expression of collagen I mRNA was quantitatively analysed by real-time PCR. At 
a high seeding density (Figure 6A), the collagen I mRNA level underwent a uniform 
upregulation as the cell culture progressed from day 8 to day 11 in all three treatments. 
Across treatments, TFP resulted in increased expression compared to FBS, and was 
countered by curcumin supplementation to levels comparable to that of FBS. When 
seeding density was lower (Figure 6B), upregulation was also seen under FBS treatment, 
with similar levels to TFP-treated samples and the inhibitory effect of curcumin was still 
apparent. Across the samples, TFP did not cause any further increase compared to FBS, 
and curcumin supplementation lowered the expression to levels below that of FBS. 
Despite a similar trend observed in experiments done on different donors (n=3), average 
results did not reach significance due to different magnitude of response by different 
donor’s cells to the treatments. However, the trend of collagen I expression under the 
three conditions are similar. Figures shown are representative of three experiments using 
cells obtained from three donors. Immunostaining carried out on day 7 and 14 did not 

















































Figure 6: Expression of collagen I in chondrocytes at monolayer culture. 
 
Cells were seeded at high (A) and low (B) densities in monolayer culture. On day 8 and 
11, RNA samples were collected and expression of collagen I was analysed by 
quantitative real-time PCR. Mean expression level of collagen I was normalised to 
GAPDH, and expressed relative to day 0 of isolated chondrocytes' expression level. Data 
were expressed as mean. Values are representative of 3 experiments. 
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 3.1.4 Expression of type II collagen during monolayer expansion 
 
To detect for changes in synthesis of chondrogenic marker collagen II, real-time 
PCR was used. Collagen II mRNA levels were only detected in cells treated with FBS 
(Figure 7A, B) which displayed a higher level at higher seeding density (Figure 7A, B). 
The exposure of chondrocytes to TFP drastically reduced collagen II mRNA expression 
level regardless of seeding density, and curcumin did not have an effect on the decline 
(Figure 7A, B). The reduction in both TFP and TFPCu groups was observed on day 8 and 
lasted till day 11.  
 
The expression of collagen II protein at high seeding density (Figure 7C) mirrors 
the mRNA pattern, where only chondrocytes grown in FBS exhibited positive staining, 
and expansion of cells from day 7 to day 14 was accompanied by a drop in the percentage 
































































Figure 7: Expression of collagen II in chondrocytes  at monolayer culture. 
 
Cells were seeded at high (A) and low (B) densities in monolayer culture. On day 8 and 
11, RNA samples were collected and expression of collagen II was analysed by 
quantitative real-time PCR. Mean expression level of collagen II was normalised to 
GAPDH, and expressed relative to day 0 of isolated chondrocytes' expression level. Data 
were expressed as mean. Values are representative of 3 experiments. Chondrocytes 
cultured for 7 and 14 days at high seeding density were stained for collagen II protein (C) 
detection (green fluorescence). Samples were counterstained for DAPI (blue). 
Magnification is taken at 100x. 
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 3.2 Redifferentiation of expanded chondrocytes in pellet culture 
 
3.2.1 Redifferentiation ability of passage 0 against passage 1 chondrocytes 
expanded at monolayer  
 
Chondrocytes were cultured in FBS medium in monolayer at Passage 0 and 
further expanded to passage 1.  The expanded cells were subjected to 3D pellet culture to 
analyse their ability to undergo redifferentiation.  Redifferentiation ability of day 28 FBS-
expanded passage 0 cells was indicated by the well-distributed deposition of 
proteoglycan as stained by alcian blue and positive immunohistochemical detection of 
collagen II (Figure 8) and absence of collagen I.  For cells expanded in FBS till passage 
1, redifferentiation ability was lost as shown by the lack of proteoglycan and collagen II 
protein expression in the 3D pellet samples (Figure 9). Due to the inability of P1 






Figure 8: Redifferentiation ability of FBS-expanded P0 chondrocytes 
 
Passage 0 cells were monolayer-cultured at low seeding density under FBS, TFP and 
TFPCu treatments. Upon confluence, redifferentiation by pellet culture was performed 
and pellets were harvested on day 28 and stained for cartilage-specific markers aggrecan 







Figure 9: Redifferentiation ability of FBS-expanded P1 chondrocytes. 
 
Passage 1 cells were monolayer-cultured at low seeding density under FBS, TFP and 
TFPCu treatments. Upon confluence, redifferentiation by pellet culture was performed 
and pellets were harvested on day 28 and stained for cartilage-specific markers aggrecan 
(Alcian blue), collagen II and I. Magnification is taken at 100x 
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 3.2.2 Redifferentiation ability of chondrocytes expanded at monolayer seeded at 
low and high seeding density 
 
 To evaluate effect of seeding density on cells' proliferation, P0 chondrocytes 
expanded under high and low seeding densities were grown in pellet culture. Across the 
treatments, chondrocytes seeded at high density was collagen II positive by day 14 
(Figure 10A). Seeding at low density delayed the onset of collagen II protein synthesis to 
day 21 (Figure 10B) and at day 28, all treatments regardless of seeding density expressed 
high levels of collagen II. A better distribution was seen under high density condition at 


























Figure 10: Re-differentiation ability of P0 monolayer-expanded chondrocytes  
 
Passage 0 chondrocytes seeded at lower and higher density were exposed to the 3 
different treatments during monolayer expansion. Redifferentiation by pellet culture was 
carried out for 14 days (A), 21 (B) and 28 days (C) and pellets assayed for collagen II 
protein expression by immunostaining. Magnification is taken at 100x. 
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 3.2.3 Cartilage phenotype of the redifferentiated chondrocytes 
 
 Cartilage phenotype was explored through analysing the expression of collagen II 
and I when P0 chondrocytes were subjected to rediferentiation. Deposition of collagen II 
was detected in both TFP and TFPCu treated samples, Expression of collagen I was 
detected in TFP-treated chondrocytes on day 21 and 28 and the presence of curcumin in 
the TFPCu samples substantially reduced collagen I expression, effective from day 21 
(Figure 11A) to 28 (Figure 11B). 
 
 In comparing effect of cells expanded at different seeding densities, although 
redifferentiation in TFP-treated samples was detected as indicated by the deposition of 
collagen II, the ratio of collagen II to collagen I expression was visibly lower in cells 
expanded at lower seeding density (Figure 12 compared to Figure 11A). A similar 
reduction in collagen I was seen in TFPCu-treated samples that were seeded at low 
density. However, this was accompanied by loss of collagen II expression. Half of the 
TFPCu-treated samples registered less collagen II expression compared to the other 






























Figure 11: Redifferentiation ability of TFP and TFPCu chondrocytes expanded at 
high seeding density. 
 
Passage 0 chondrocytes were cultured separately under FBS, TFP and TFPCu conditions 
during monolayer expansion, at high density. Redifferentiation through pellet culture was 
done for 21 days (A) and 28 days (B). Pellets were stained for cartilage-specific markers 







Figure 12: Redifferentiation ability of TFP and TFPCu chondrocytes expanded at 
low seeding density. 
 
Passage 0 chondrocytes were cultured under FBS, TFP and TFPCu conditions during 
monolayer expansion, at low density. Redifferentiation through pellet culture was done 
for 21 days. Pellets were stained for cartilage-specific markers aggrecan (Alcian blue), 


















Cartilage is a sparsely populated tissue that yields a very low number of cells 
upon chondrocyte isolation. The yield from an average size of 300 - 500 mg biopsy is 
only 0.18 – 0.45 million (Brittberg, Lindahl et al. 1994). This brings forth the need to 
expand the cells to meet the requirement of obtaining 40 million cells to fill a defect 
measuring 4cm2 in an ACI procedure. The current practice of expanding cells under FBS 
treatment necessitates passaging to make up for the low cell yield resulting from slow 
proliferation rates that are distinctive of the specialized adult human articular 
chondrocytes. The low proliferation rates of chondrocytes also translate into ACI being a 
lengthy process due to the long time of 3-5 weeks taken for cell expansion in the 
laboratory. This limitation has been overcome with the introduction of growth factors 
during cell expansion, to accelerate the multiplication of cells (Jakob, Demarteau et al. 
2001; Barbero, Ploegert et al. 2003). Cells subjected to a cocktail of TGFβ1, βFGF and 
PDGF-ββ (TFP) treatment possessed population doublings that are significantly reduced. 
At confluence the total cell yield upon usage of TFP is 3.5-7.6 folds higher than when 
cells were grown in basal FBS medium, seeded and expanded over the same period. A 
similar cell yield under TFP treatment was reported where compared to control, TFP’s 
effect on amplifying cell numbers was noted to start on the fifth day of culture, resulting 
in a 4 fold increase at confluency (Barbero, Palumberi et al. 2005). However our results 
showed that increased proliferation was accompanied by an early loss of chondrogenic 
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marker Collagen II during monolayer expansion, as seen from the real-time PCR reaction 
and immunohistochemical staining of TFP-treated cells from a time point of day 7, and a 
gain in collagen I level as observed at the mRNA level. These fit into the description of 
dedifferentiation. Therefore it is postulated that increased proliferation is followed 
closely by an earlier dedifferentiation. Our results was in accordance to Jakob et al where 
growth factors were concluded to cause increased proliferation that was  accompanied by 
increased dedifferentiation (Jakob, Demarteau et al. 2001) as compared to FBS.  
 
The loss of chondrogenic phenotype experienced during monolayer expansion is 
not fully reversible. It has been reported that dedifferentiation leaves only around 80% of 
the population with reversibility to redifferentiate (Benya and Shaffer 1982) and it was 
highlighted that redifferentiated chondrocytes generated cartilage that were of 
increasingly fibrous nature (Peterson, Brittberg et al. 2002).  As such, we investigated the 
redifferentiation ability and the phenotype of the cartilage formed by the TFP-expanded 
cells. The redifferentiated chondrocytes had a higher tendency to form tissues that were 
of mixed hyaline and fibrocartilage quality as compared to the FBS-expanded cells. 
Although abundant proteoglycan and collagen II was synthesized, we detected substantial 
deposition of collagen I in the TFP-expanded cells (Figure 11). Deposition of collagen I 
occurred at a lower frequency and in much lesser degree in FBS-expanded cells (Figure 
8). This is indicative of a possible disadvantage of supplementing the growth media with 
TFP cocktail. To the best of our knowledge, the observation of a mixed hyaline and 
fibrocartilage formation by TFP-expanded cells is novel and has not been reported by 
others. It must be noted though that this observation was based on osteoarthritic cells, 
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while majority of previous investigations carried out on TFP growth medium were 
utilizing healthy chondrocytes (Jakob, Demarteau et al. 2001; Barbero, Ploegert et al. 
2003). The possibility of hyaline and fibrocartilage tissue formation by TFP-expanded 
cells from a healthy source of chondrocytes will need to be investigated.   
 
Activation of Wnt/β-catenin signaling has been attributed to the de-differentiation 
of chondrocytes (Hwang, Ryu et al. 2004). Our analysis of the β-catenin expression levels 
during monolayer-expansion of the chondrocytes showed an earlier and heightened 
expression of β-catenin in the TFP-expanded cells, both at the mRNA and protein levels 
(Figure 5).  Inclusion of curcumin in the TFP cocktail reduced β-catenin mRNA and 
protein levels in the expansion phase at all time points which was accompanied by a 
reduction in collagen I mRNA expression. Importantly, subsequent redifferentiation of 
cells expanded in TFP plus curcumin distinctly reduced collagen I deposition, without 
affecting proteoglycan and collagen II production, as compared to TFP treatment. The 
redifferentiation outcome of the TFPCu expanded cells is similar to the FBS expanded 
cells which showcased hyaline-like ECM. Notably, although β-catenin mRNA levels was 
expressed in FBS expanded cells, albeit at levels lower than TFP-treated cells, β-catenin 
protein was detected only in the TFP treated cells. This suggests an association between 
β-catenin expression and subsequent redifferentiated tissue quality. The expression level 
of β-catenin during dedifferentiation phase might influence the outcome of the 
subsequent redifferentiation, with a high β-catenin level predisposing the cells to form a 
fibrocartilaginous tissue and a low β-catenin level leading to a hyaline tissue. 
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The observed reduction in β-catenin levels following curcumin treatment during 
dedifferentiation could perhaps be explained by the work from others that have shown 
curcumin-induced β-catenin degradation. The degradation led to reduced β-catenin 
protein levels in the nucleus (Park, Hahm et al. 2005) which resulted in decreased 
transcriptional activity of β-catenin/TCF-LEF complex (Jaiswal, Marlow et al. 2002) and 
suppression of β-catenin/TCF signaling. However, it must be commented that these 
findings were made in cancer cell lines.  Curcumin’s effects on β-catenin reduction have 
not been published on chondrocytes. Among the few publications that experimented with 
curcumin usage in chondrocytes, curcumin’s anti-inflammatory effect was shown through 
its inhibitory response to a IL-6 cytokine member by downregulating expression of 
catabolic markers like MMP13 and MMP1 (Li, Dehnade et al. 2001). In a separate report 
on chondrocytes, curcumin's inhibitory action was similarly documented, countering the 
effects of IL-1β by reversing the downregulation of collagen II (Shakibaei, John et al. 
2007). The effect from combining curcumin and TFP medium have also not been 
published on chondrocytes before, although curcumin has been found to modulate the 
effects of growth factors TGF (Santibanez, Quintanilla et al. 2000; Mani, Sidhu et al. 
2002; Gaedeke, Noble et al. 2004), FGF (Mohan, Sivak et al. 2000) and PDGF (Yang, 
Thomas et al. 2006) in other cell types. It must be emphasized that the results can only 
suggest that curcumin suppressed β-catenin through the Wnt/β-catenin signaling 
pathway. The present study cannot rule out the possibility that other pathways were 
equally or more involved in the β-catenin suppression. The protein kinase signaling 
pathway involving protein kinase C (PKC) has been found to modulate the 
dedifferentiation of chondrocytes and affected β-catenin expression during 
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redifferentiation (Yoon, Kim et al. 2002). The mitogen-activated protein kinase signaling 
pathway (MAPK) has also been suggested to influence the maintenance of chondrogenic 
capacity due to its engagement in the de- and rediferentiation of many cell types 
(Schulze-Tanzil, Mobasheri et al. 2004). Cross-talk between different pathways has also 
been reported. It is well-known that activated TFs can affect several pathways at any 
given time. A comprehensive investigation on the signaling pathways involved in the 
elucidation of β-catenin inhibition could be carried out by using the microarray method. 
 
The inclusion of curcumin was observed to diminish the enhanced proliferation 
and attachment effects of TFP in the initial 9 days of monolayer expansion. Nevertheless, 
the final cell count of 2.9-6.7 folds higher than FBS medium makes it comparable to TFP 
treatment. The inconsistency between the results of MTT assay and PD count for TFP 
and TFPCu could probably be pinned down to a difference in initial cell attachment, and 
that cells which attached have the same population doubling ability regardless of 
curcumin. These points out that eventually the addition of curcumin did not compromise 
or impede the enhanced proliferation conferred by the TFP cocktail, and still produced a 
much higher cell yield at the end of treatment in contrast to the usage of FBS medium 
alone (Table 3). Ensuing from the increased proliferation rates seen with TFP and TFPCu 
treatment, the monolayer expansion period is noticeably shortened to about 10.6-15 days, 
compared to 14.5-17.3 days under FBS treatment. This is supported by a published 
finding that TFP decreased the time for first cell division by 26.6%, and subsequent cell 
division by 16.8% and percentage of quiescent cells by 42.5% (Barbero, Palumberi et al. 
2005). 
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 The ability to obtain significantly higher cell numbers earlier through the use of 
TFP and TFPCu confers a two-pronged advantage for the subsequent redifferentiation. 
First of all, although a comparative investigation between different seeding densities for 
pellet formation was not performed in this study, publications have shown that for 
successful redifferentiation, high cell numbers are preferable. The implantation of cells at 
high density generated tissue of increased diameter and thickness, with significantly 
improved biochemical and biomechanical properties (Mauck, Wang et al. 2003). A higher 
yield of monolayer expanded cells will allow for higher seeding density that will lead to 
superior cartilage regeneration. Secondly, extended expansion time and passaging 
number could then be avoided during ex vivo expansion, which will result in reduced de-
differentiation. Cells have been found to be more primed for redifferentiation with lower 
passage state. Both results from us and others (Diaz-Romero, Nesic et al. 2008) have 
shown that passaging might not be ideal since loss of phenotype, observed from the lack 
of collagen II and cartilaginous ECM synthesis, have been noted when the chondrocytes 
were subjected to redifferentiation conditions. Even though P1 cells have been suggested 
to be the uplimit for recapitulating chondrogenesis (Cournil-Henrionnet, Huselstein et al. 
2008), our results showed that even at P0, collagen II is gradually lost during monolayer 
expansion as culture progressed from day 7 to day 14. In our study, using cartilage 
obtained from total knee replacement, by passage 1, expanded cells have undergone a 
drastic and complete loss of their chondrogenic ability during the redifferentiation 
procedure (Figure 9), indicative of irreversible dedifferentiation. The cells failed to 
synthesize any collagens and very minimal amounts of proteoglycans. This is in contrary 
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to the results from others (Dell'Accio, De Bari et al. 2001; Barbero, Ploegert et al. 2003; 
Schulze-Tanzil, Mobasheri et al. 2004) where they have shown that at P2 and P4 
respectively, chondrocytes were still capable of redifferentiating into cells which 
synthesized cartilaginous ECM. This could be due to a few reasons. Differences in 
conditions during monolayer expansion could be a factor. High seeding density of 
between 10 000 and 50 000 cells/cm2 were used in the monolayer expansion carried out 
by Barbero et al (Barbero, Ploegert et al. 2003) and Accio et al (Dell'Accio, Vanlauwe et 
al. 2003) while we used 2667 cells/cm2. It has been reported that high seeding density 
stabilizes the chondrocyte phenotype more and thus creates a more conducive 
environment for redifferentiation (Watt 1988; Schulze-Tanzil, de Souza et al. 2002). 
Another contributing factor could be due to the type of cell source. The publications used 
either post-mortem chondrocytes (Dell'Accio, De Bari et al. 2001), joint replacement 
samples from neck fractures (Schulze-Tanzil, Mobasheri et al. 2004) or samples from 
individuals without history of joint disease (Barbero, Ploegert et al. 2003). These can be 
assumed and categorized as relatively young and healthy chondrocytes which were 
shown to retain better chondrocyte phenotype (Thirion and Berenbaum 2004). Our study 
might be disadvantaged due to the usage of osteoarthritic cells from highly aged patients 
as chondrocytes were found to synthesize less collagen II with increasing age (Brandl, 
Angele et al. 2009) and OA chondrocytes was shown to contain mitochondria with 
diminished DNA integrity (Grishko, Ho et al. 2009). Defects in cells’ function have been 
reported in connection with damaged mitrochondrial DNA in the same paper (Grishko, 
Ho et al. 2009). However, the easy availability of obtaining TKR samples meant for 
disposal compared to the very infrequent cases of obtaining healthy samples, led to the 
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usage of osteoarthritic cells in our study.  The concentration of the growth factors could 
have also played a part in causing the disparity. Barbero et al (Barbero, Ploegert et al. 
2003; Barbero, Palumberi et al. 2005) used 10 ng/ml of PDGF-ββ while we used 5 ng/ml 
of the same growth factor. Growth factors have been shown to exert different biological 
actions at different concentrations (Jonsson, Nilsson et al. 1997). Our results are 
supported further by a research finding which concluded that despite unchanged growth 
rates between P1 and P2 chondrocytes, the fraction of fast cells (Gt < 16hrs) decreased 
dramatically from P1 to P2 chondrocytes. In the same publication, it was reported that the 
ability to form stable cartilage is reduced with increasing passage (Dell'Accio, De Bari et 
al. 2001), with complete loss reported to be between P2 and P3, equating to a population 
doubling of 4 to 6.  
 
The seeding density at the start of monolayer expansion also proved to play a part 
in modulating the cells’ chondrogenic potential. Across all treatments, high seeding 
density shortened the monolayer culture period by a few days as seen in Table 3. β-
catenin level was shown to be less when seeding was higher in samples across the 
treatments, with TFPCu showing the highest inhibition of β-catenin expression, 
indicating that the inhibitory effect of TFPCu was seeding-dependent and could be 
executed better at higher seeding. A better retention of phenotype was observed when 
cells were seeded at higher density (Figure 7B, C). This is further confirmed with the 
redifferentiation ability of cells, where high seeding reduced the collagen I level without 
compromising the production of collagen II (Figure 11), unlike at low seeding density 
(Figure 12). Although the results obtained showed that higher seeding density is better for 
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a successful redifferentiation, this density of 2667 cells/cm2 which we used was in fact 
low compared to others, where 3500 cells/cm2 is considered to be low (Mandl, van der 
Veen et al. 2004). The combined analyzed results showed that a seeding density of 2667 
cells/cm2 seems to be an acceptable value for recapitulating chondrogenic potential, but 
at 667 cells/cm2, cells have a higher penchant for undergoing irreversible 
dedifferentiation. At this low seeding density, even the inclusion of TFP during 
expansion, in the presence and absence of curcumin, was not able to retain the 
chondrogenic differentiation potential of the expanded cells.  
 
Lastly and most importantly, we have shown that the inclusion of curcumin in the 
TFP cocktail has the dual advantage of maintaining the higher and faster cell yield 
conferred by TFP treatment, and at the same time reducing the de-differentiation 
disadvantage posed by TFP. We were able to show that the inhibition of β-catenin by 
curcumin resulted in the formation of hyaline cartilage. This conflicts with the findings of 
Zhu et al (Zhu, Chen et al. 2008) where Col2a1-ICAT-transgenic mice blocked β-catenin 
signaling but also destroyed cartilage. However, the difference could be attributed to the 
animal model used and the degree of β-catenin suppression. Zhu et al used a mouse 
model that might not accurately mimic the response of human articular chondrocytes. 
The permanent in vivo suppression of β-catenin in the transgenic mice would also be at a 
much higher level compared to the transient inhibition of β-catenin noted on the 11th and 
14th day of monolayer expansion in curcumin treated cells (Figure 5A). This highlights 
the advantage conferred by using a chemical to enforce a transient β-catenin inhibition as 
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compared to a permanent inhibition achieved by β-catenin gene knockdown which led to 
















5.1 Conclusion of this study 
 
This study aimed to investigate the inhibition of chondrocyte phenotype loss 
during in vitro expansion through antagonizing the Wnt/β-catenin signaling pathway. The 
objective is to generate cartilage of a higher degree of hyaline quality for ACI repair.  In 
comparison to the FBS treatment, TFP cocktail led to accelerated proliferation resulting 
in a significantly increased cell yield within a shorter time.  However, β-catenin protein 
and collagen I was also upregulated during this expansion phase. Subsequent 
redifferentiation of these chondrocytes later resulted in a mixed fibro- and hyaline 
cartilage tissue. Supplementation with curcumin did not significantly alter the 
proliferative effect of TFP but reversed the TFP-induced β-catenin upregulation and 
resulted in a purer hyaline cartilage formation. Higher seeding conditions also proved to 
be advantageous in retaining cartilage phenotype. Our results suggest an association 
between β-catenin expression and subsequent redifferentiated tissue quality. Addition of 
curcumin in conjunction with growth factor cocktail during monolayer expansion led to 
the formation of purer, more hyaline cartilage. This holds promising clinical value 
because current cartilage repair techniques have been shown to lead to fibrocartilage 
formation for the first few years of postoperative recovery period, only to be replaced 
with the biomechanically superior hyaline cartilage much later on. If the results could be 
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repeated in an in vivo setting, it could translate to a faster healing for patients suffering 
from cartilage defects and degeneration.  
 
5.2 Limitations and future directions 
 
According to Andrea Barbero et al, reproducible results with TFP can only be 
obtained from patients younger than 40 years old (Barbero, Grogan et al. 2004). The 
samples used in this experiment are osteoarthritic, and were beyond the limit concluded 
by the group, at an average of 69 years of age (age range 57-91 years old). Although it 
was found that OA cells still contain a population of MSCs that can still be of therapeutic 
use (Mareddy, Crawford et al. 2007), researchers have been cautioned against using 
osteoarthritic cells because by the time TKR procedure is carried out, the cartilage would 
have undergone extensive physical and physiological alterations (Wieland, Michaelis et 
al. 2005). 
 
Differences in age, the balance of anabolic and catabolic metabolism for the cells, 
physiological state of the cells or homogeneity of the chondrocyte population could 
enhance or lead to the variations observed in the results of our study. For better, 
statistically significant results, it would be useful to normalize the cell source by having 
stricter selection criteria. The use of healthy chondrocytes from donors who are healthy 
and have not been taking medication that might affect the cartilage would obviously be a 
better choice. However, tissues that fit these conditions are hard to come by. Other 
possible healthy cell sources could be normal human knee cartilage from trauma patients 
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or fresh cadaveric samples. For the purpose of standardization, young chondrocytes 
would be optimal to avoid sample variability. Alternatively, chondrocytes from animal 
cartilage could be considered. 
 
Curcumin could have exerted its inhibitory effect effects through various 
signaling pathways other than β-catenin signaling. The data only suggests the possible 
link between β-catenin level during dedifferentiation and cartilage tissue quality after 
redifferentiation.  A definitive indication of β-catenin involvement in de-differentiation 
and loss of cartilage phenotype can only be confirmed with the use of specific inhibitors 

















Table 1. Primers used for Real-Time PCR 





GAPDHR: 5'-TAAAAGCAGCCCTGGTGACC-3’  
119 
Collagen IIF: 5'-GGCAATAGCAGGTTCACGTACA-3’ Collagen 
II Collagen IIR: 5'-CGATAACAGTCTTGCCCCACTT-3’. 
79 
Collagen IF: 5'-CAGCCGCTTCACCTACAGC-3' Collagen 
I Collagen IR: 5'-TTTTGTATTCAATCACTGTCTTGCC-3' 
83 
 
Table 2. Primers used for Conventional PCR 

































Abbott, J. and H. Holtzer (1966). "The loss of phenotypic traits by differentiated cells. 3. 
The reversible behavior of chondrocytes in primary cultures." J Cell Biol 28(3): 
473-487. 
Aggarwal, B. B. and B. Sung (2009). "Pharmacological basis for the role of curcumin in 
chronic diseases: an age-old spice with modern targets." Trends Pharmacol Sci 
30(2): 85-94. 
Aggarwal, S., H. Ichikawa, et al. (2006). "Curcumin (diferuloylmethane) down-regulates 
expression of cell proliferation and antiapoptotic and metastatic gene products 
through suppression of IkappaBalpha kinase and Akt activation." Mol Pharmacol 
69(1): 195-206. 
Aigner, T., S. Soder, et al. (2007). "Mechanisms of disease: role of chondrocytes in the 
pathogenesis of osteoarthritis--structure, chaos and senescence." Nat Clin Pract 
Rheumatol 3(7): 391-399. 
Aulthouse, A. L., M. Beck, et al. (1989). "Expression of the human chondrocyte 
phenotype in vitro." In Vitro Cell Dev Biol 25(7): 659-668. 
Bafico, A., G. Liu, et al. (2001). "Novel mechanism of Wnt signalling inhibition 
mediated by Dickkopf-1 interaction with LRP6/Arrow." Nat Cell Biol 3(7): 683-
686. 
Baltzer, A. W., C. Moser, et al. (2009). "Autologous conditioned serum (Orthokine) is an 
effective treatment for knee osteoarthritis." Osteoarthritis Cartilage 17(2): 152-
160. 
Barbero, A., S. Grogan, et al. (2004). "Age related changes in human articular 
chondrocyte yield, proliferation and post-expansion chondrogenic capacity." 
Osteoarthritis Cartilage 12(6): 476-484. 
Barbero, A., V. Palumberi, et al. (2005). "Experimental and mathematical study of the 
influence of growth factors on the growth kinetics of adult human articular 
chondrocytes." J Cell Physiol 204(3): 830-838. 
Barbero, A., S. Ploegert, et al. (2003). "Plasticity of clonal populations of dedifferentiated 
adult human articular chondrocytes." Arthritis Rheum 48(5): 1315-1325. 
Barker, N. and H. Clevers (2000). "Catenins, Wnt signaling and cancer." Bioessays 
22(11): 961-965. 
Barker, N. and H. Clevers (2006). "Mining the Wnt pathway for cancer therapeutics." Nat 
Rev Drug Discov 5(12): 997-1014. 
Bartlett, W., J. A. Skinner, et al. (2005). "Autologous chondrocyte implantation versus 
matrix-induced autologous chondrocyte implantation for osteochondral defects of 
the knee: a prospective, randomised study." J Bone Joint Surg Br 87(5): 640-645. 
Behrens, P., T. Bitter, et al. (2006). "Matrix-associated autologous chondrocyte 
transplantation/implantation (MACT/MACI)--5-year follow-up." Knee 13(3): 
194-202. 
 77
Benya, P. D. and J. D. Shaffer (1982). "Dedifferentiated chondrocytes reexpress the 
differentiated collagen phenotype when cultured in agarose gels." Cell 30(1): 215-
224. 
Bonaventure, J., N. Kadhom, et al. (1994). "Reexpression of cartilage-specific genes by 
dedifferentiated human articular chondrocytes cultured in alginate beads." Exp 
Cell Res 212(1): 97-104. 
Brandl, A., P. Angele, et al. (2009). "Influence of the growth factors PDGF-BB, TGF-
beta1 and bFGF on the replicative aging of human articular chondrocytes during 
in vitro expansion." J Orthop Res. 
Brittberg, M., A. Lindahl, et al. (1994). "Treatment of deep cartilage defects in the knee 
with autologous chondrocyte transplantation." N Engl J Med 331(14): 889-895. 
Brower, T. D. and W. Y. Hsu (1969). "Normal articular cartilage." Clin Orthop Relat Res 
64: 9-17. 
Buckwalter, J. A. and H. J. Mankin (1998). "Articular cartilage repair and 
transplantation." Arthritis Rheum 41(8): 1331-1342. 
Chen A. C., K. S. M., Bae. W. C., Temple M. M., McGowan K. B., Gratz K. R., 
Schumacher B. L., Sah R. L. (2004). Mechanical Characterization of Native and 
Tissue-Engineered Cartilage. Cartilage and Osteoarthritis: Volume 2: Structure 
and In Vivo Analysis (Methods in Molecular Medicine), Springer Protocols. 101. 
Chung, C. and J. A. Burdick (2008). "Engineering cartilage tissue." Adv Drug Deliv Rev 
60(2): 243-262. 
Corr, M. (2008). "Wnt-beta-catenin signaling in the pathogenesis of osteoarthritis." Nat 
Clin Pract Rheumatol 4(10): 550-556. 
Cournil-Henrionnet, C., C. Huselstein, et al. (2008). "Phenotypic analysis of cell surface 
markers and gene expression of human mesenchymal stem cells and chondrocytes 
during monolayer expansion." Biorheology 45(3-4): 513-526. 
Darling, E. M. and K. A. Athanasiou (2005). "Growth factor impact on articular cartilage 
subpopulations." Cell Tissue Res 322(3): 463-473. 
Darling, E. M. and K. A. Athanasiou (2005). "Rapid phenotypic changes in passaged 
articular chondrocyte subpopulations." J Orthop Res 23(2): 425-432. 
De Ceuninck, F., C. Lesur, et al. (2004). "Culture of chondrocytes in alginate beads." 
Methods Mol Med 100: 15-22. 
Dell'Accio, F., C. De Bari, et al. (2001). "Molecular markers predictive of the capacity of 
expanded human articular chondrocytes to form stable cartilage in vivo." Arthritis 
Rheum 44(7): 1608-1619. 
Dell'Accio, F., J. Vanlauwe, et al. (2003). "Expanded phenotypically stable chondrocytes 
persist in the repair tissue and contribute to cartilage matrix formation and 
structural integration in a goat model of autologous chondrocyte implantation." J 
Orthop Res 21(1): 123-131. 
Diaz-Romero, J., J. P. Gaillard, et al. (2005). "Immunophenotypic analysis of human 
articular chondrocytes: changes in surface markers associated with cell expansion 
in monolayer culture." J Cell Physiol 202(3): 731-742. 
Diaz-Romero, J., D. Nesic, et al. (2008). "Immunophenotypic changes of human articular 
chondrocytes during monolayer culture reflect bona fide dedifferentiation rather 
than amplification of progenitor cells." J Cell Physiol 214(1): 75-83. 
 78
Drissi, H., M. Zuscik, et al. (2005). "Transcriptional regulation of chondrocyte 
maturation: potential involvement of transcription factors in OA pathogenesis." 
Mol Aspects Med 26(3): 169-179. 
Evans, C. H. and H. I. Georgescu (1983). "Observations on the senescence of cells 
derived from articular cartilage." Mech Ageing Dev 22(2): 179-191. 
Freemont, A. J. and J. Hoyland (2006). "Lineage plasticity and cell biology of 
fibrocartilage and hyaline cartilage: its significance in cartilage repair and 
replacement." Eur J Radiol 57(1): 32-36. 
Frenkel, S. R. and P. E. Di Cesare (1999). "Degradation and repair of articular cartilage." 
Front Biosci 4: D671-685. 
Freudlsperger, C., J. Greten, et al. (2008). "Curcumin induces apoptosis in human 
neuroblastoma cells via inhibition of NFkappaB." Anticancer Res 28(1A): 209-
214. 
Fukumoto, T., J. W. Sperling, et al. (2003). "Combined effects of insulin-like growth 
factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells 
during chondrogenesis in vitro." Osteoarthritis Cartilage 11(1): 55-64. 
Gaedeke, J., N. A. Noble, et al. (2004). "Curcumin blocks multiple sites of the TGF-beta 
signaling cascade in renal cells." Kidney Int 66(1): 112-120. 
Getgood, A., R. Brooks, et al. (2009). "Articular cartilage tissue engineering: today's 
research, tomorrow's practice?" J Bone Joint Surg Br 91(5): 565-576. 
Gikas, P. D., T. Morris, et al. (2009). "A correlation between the timing of biopsy after 
autologous chondrocyte implantation and the histological appearance." J Bone 
Joint Surg Br 91(9): 1172-1177. 
Grimaud, E., D. Heymann, et al. (2002). "Recent advances in TGF-beta effects on 
chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage 
disorders." Cytokine Growth Factor Rev 13(3): 241-257. 
Grishko, V. I., R. Ho, et al. (2009). "Diminished mitochondrial DNA integrity and repair 
capacity in OA chondrocytes." Osteoarthritis Cartilage 17(1): 107-113. 
Guerne, P. A., F. Blanco, et al. (1995). "Growth factor responsiveness of human articular 
chondrocytes in aging and development." Arthritis Rheum 38(7): 960-968. 
Hatcher, H., R. Planalp, et al. (2008). "Curcumin: from ancient medicine to current 
clinical trials." Cell Mol Life Sci 65(11): 1631-1652. 
Hayflick, L. (1965). "The Limited in Vitro Lifetime of Human Diploid Cell Strains." Exp 
Cell Res 37: 614-636. 
He, X., J. P. Saint-Jeannet, et al. (1995). "Glycogen synthase kinase-3 and dorsoventral 
patterning in Xenopus embryos." Nature 374(6523): 617-622. 
Ho, S. T., Z. Yang, et al. (2009). "A serum free approach towards the conservation of 
chondrogenic phenotype during in vitro cell expansion." Growth Factors 27(5): 
321-333. 
Holtzer, H., J. Abbott, et al. (1960). "The Loss of Phenotypic Traits by Differentiated 
Cells in Vitro, I. Dedifferentiation of Cartilage Cells." Proc Natl Acad Sci U S A 
46(12): 1533-1542. 
Hwang, S. G., J. H. Ryu, et al. (2004). "Wnt-7a causes loss of differentiated phenotype 
and inhibits apoptosis of articular chondrocytes via different mechanisms." J Biol 
Chem 279(25): 26597-26604. 
 79
Jaiswal, A. S., B. P. Marlow, et al. (2002). "Beta-catenin-mediated transactivation and 
cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced 
growth arrest and apoptosis in colon cancer cells." Oncogene 21(55): 8414-8427. 
Jakob, M., O. Demarteau, et al. (2001). "Specific growth factors during the expansion 
and redifferentiation of adult human articular chondrocytes enhance 
chondrogenesis and cartilaginous tissue formation in vitro." J Cell Biochem 81(2): 
368-377. 
Jingushi, S., J. Shida, et al. (2006). "Transient exposure of fibroblast growth factor-2 
induced proliferative but not destructive changes in mouse knee joints." Connect 
Tissue Res 47(4): 242-248. 
Johnstone, B., T. M. Hering, et al. (1998). "In vitro chondrogenesis of bone marrow-
derived mesenchymal progenitor cells." Exp Cell Res 238(1): 265-272. 
Jonsson, J. I., K. Nilsson, et al. (1997). "Concentration-dependent effects of 
hematopoietic growth factors during in vitro expansion of mouse stem cells and 
progenitor cells." Growth Factors 14(1): 59-66. 
Jung, Y., S. Bang, et al. (2006). "TC1 (C8orf4) enhances the Wnt/beta-catenin pathway 
by relieving antagonistic activity of Chibby." Cancer Res 66(2): 723-728. 
Kawano, Y. and R. Kypta (2003). "Secreted antagonists of the Wnt signalling pathway." 
J Cell Sci 116(Pt 13): 2627-2634. 
Kieswetter, K., Z. Schwartz, et al. (1997). "Platelet derived growth factor stimulates 
chondrocyte proliferation but prevents endochondral maturation." Endocrine 6(3): 
257-264. 
Kolettas, E., L. Buluwela, et al. (1995). "Expression of cartilage-specific molecules is 
retained on long-term culture of human articular chondrocytes." J Cell Sci 108 ( 
Pt 5): 1991-1999. 
Li, W. Q., F. Dehnade, et al. (2001). "Oncostatin M-induced matrix metalloproteinase 
and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes 
requires Janus kinase/STAT signaling pathway." J Immunol 166(5): 3491-3498. 
Mandl, E. W., S. W. van der Veen, et al. (2002). "Serum-free medium supplemented with 
high-concentration FGF2 for cell expansion culture of human ear chondrocytes 
promotes redifferentiation capacity." Tissue Eng 8(4): 573-580. 
Mandl, E. W., S. W. van der Veen, et al. (2004). "Multiplication of human chondrocytes 
with low seeding densities accelerates cell yield without losing redifferentiation 
capacity." Tissue Eng 10(1-2): 109-118. 
Mani, H., G. S. Sidhu, et al. (2002). "Curcumin differentially regulates TGF-beta1, its 
receptors and nitric oxide synthase during impaired wound healing." Biofactors 
16(1-2): 29-43. 
Mao, B., W. Wu, et al. (2001). "LDL-receptor-related protein 6 is a receptor for Dickkopf 
proteins." Nature 411(6835): 321-325. 
Mareddy, S., R. Crawford, et al. (2007). "Clonal isolation and characterization of bone 
marrow stromal cells from patients with osteoarthritis." Tissue Eng 13(4): 819-
829. 
Marlovits, S., P. Zeller, et al. (2006). "Cartilage repair: generations of autologous 
chondrocyte transplantation." Eur J Radiol 57(1): 24-31. 
Martel-Pelletier, J., C. Boileau, et al. (2008). "Cartilage in normal and osteoarthritis 
conditions." Best Pract Res Clin Rheumatol 22(2): 351-384. 
 80
Martin, I., G. Vunjak-Novakovic, et al. (1999). "Mammalian chondrocytes expanded in 
the presence of fibroblast growth factor 2 maintain the ability to differentiate and 
regenerate three-dimensional cartilaginous tissue." Exp Cell Res 253(2): 681-688. 
Martin, J. A. and J. A. Buckwalter (2001). "Telomere erosion and senescence in human 
articular cartilage chondrocytes." J Gerontol A Biol Sci Med Sci 56(4): B172-179. 
Martin, J. A. and J. A. Buckwalter (2002). "Human chondrocyte senescence and 
osteoarthritis." Biorheology 39(1-2): 145-152. 
Martin, J. A. and J. A. Buckwalter (2003). "The role of chondrocyte senescence in the 
pathogenesis of osteoarthritis and in limiting cartilage repair." J Bone Joint Surg 
Am 85-A Suppl 2: 106-110. 
Matsusue Y, N. Y. (2002). "Arthroplasty using Mosaicplasty." Clinical Calcium 12(1): 
66-69. 
Mauck, R. L., C. C. Wang, et al. (2003). "The role of cell seeding density and nutrient 
supply for articular cartilage tissue engineering with deformational loading." 
Osteoarthritis Cartilage 11(12): 879-890. 
Mehta, K., P. Pantazis, et al. (1997). "Antiproliferative effect of curcumin 
(diferuloylmethane) against human breast tumor cell lines." Anticancer Drugs 
8(5): 470-481. 
Meijer, L., M. Flajolet, et al. (2004). "Pharmacological inhibitors of glycogen synthase 
kinase 3." Trends Pharmacol Sci 25(9): 471-480. 
Meyer, U. (2006). Bone and cartilage engineering, Springer-verlag. 
Mitchell, N. and N. Shepard (1976). "The resurfacing of adult rabbit articular cartilage by 
multiple perforations through the subchondral bone." J Bone Joint Surg Am 
58(2): 230-233. 
Mohan, R., J. Sivak, et al. (2000). "Curcuminoids inhibit the angiogenic response 
stimulated by fibroblast growth factor-2, including expression of matrix 
metalloproteinase gelatinase B." J Biol Chem 275(14): 10405-10412. 
Molenaar, M., M. van de Wetering, et al. (1996). "XTcf-3 transcription factor mediates 
beta-catenin-induced axis formation in Xenopus embryos." Cell 86(3): 391-399. 
Mow, V. C., A. Ratcliffe, et al. (1992). "Cartilage and diarthrodial joints as paradigms for 
hierarchical materials and structures." Biomaterials 13(2): 67-97. 
Nehrer, S., M. Spector, et al. (1999). "Histologic analysis of tissue after failed cartilage 
repair procedures." Clin Orthop Relat Res(365): 149-162. 
Neumann, C. and S. Cohen (1997). "Morphogens and pattern formation." Bioessays 
19(8): 721-729. 
Niedermann, B., S. Boe, et al. (1985). "Glued periosteal grafts in the knee." Acta Orthop 
Scand 56(6): 457-460. 
Ohori, H., H. Yamakoshi, et al. (2006). "Synthesis and biological analysis of new 
curcumin analogues bearing an enhanced potential for the medicinal treatment of 
cancer." Mol Cancer Ther 5(10): 2563-2571. 
Park, C. H., E. R. Hahm, et al. (2005). "The inhibitory mechanism of curcumin and its 
derivative against beta-catenin/Tcf signaling." FEBS Lett 579(13): 2965-2971. 
Park, Y., M. Sugimoto, et al. (2005). "BMP-2 induces the expression of chondrocyte-
specific genes in bovine synovium-derived progenitor cells cultured in three-
dimensional alginate hydrogel." Osteoarthritis Cartilage 13(6): 527-536. 
 81
Pei, M., J. Seidel, et al. (2002). "Growth factors for sequential cellular de- and re-
differentiation in tissue engineering." Biochem Biophys Res Commun 294(1): 
149-154. 
Peterson, L., M. Brittberg, et al. (2002). "Autologous chondrocyte transplantation. 
Biomechanics and long-term durability." Am J Sports Med 30(1): 2-12. 
Peterson L, M. D., Grande D, Pitman M (1984). Chondrocyte transplantation; an 
experimental model in the rabbit. 30th Annual Meeting Orthopedic Research 
Society. Atlanta, Orthopaedic Research Society. 218. 
Piera-Velazquez, S., S. A. Jimenez, et al. (2002). "Increased life span of human 
osteoarthritic chondrocytes by exogenous expression of telomerase." Arthritis 
Rheum 46(3): 683-693. 
Prasad, C. P., G. Rath, et al. (2009). "Potent growth suppressive activity of curcumin in 
human breast cancer cells: Modulation of Wnt/beta-catenin signaling." Chem Biol 
Interact 181(2): 263-271. 
Reddi, A. H. (2006). "Aging, osteoarthritis and transforming growth factor-beta signaling 
in cartilage." Arthritis Res Ther 8(1): 101. 
Roberts, S., A. P. Hollander, et al. (2001). "Matrix turnover in human cartilage repair 
tissue in autologous chondrocyte implantation." Arthritis Rheum 44(11): 2586-
2598. 
Roberts, S., I. W. McCall, et al. (2003). "Autologous chondrocyte implantation for 
cartilage repair: monitoring its success by magnetic resonance imaging and 
histology." Arthritis Res Ther 5(1): R60-73. 
Roberts, S., J. Menage, et al. (2009). "Immunohistochemical study of collagen types I 
and II and procollagen IIA in human cartilage repair tissue following autologous 
chondrocyte implantation." Knee 16(5): 398-404. 
Roose, J., G. Huls, et al. (1999). "Synergy between tumor suppressor APC and the beta-
catenin-Tcf4 target Tcf1." Science 285(5435): 1923-1926. 
Rosier, R. N., R. J. O'Keefe, et al. (1989). "Transforming growth factor beta: an autocrine 
regulator of chondrocytes." Connect Tissue Res 20(1-4): 295-301. 
Ryu, M. J., M. Cho, et al. (2008). "Natural derivatives of curcumin attenuate the 
Wnt/beta-catenin pathway through down-regulation of the transcriptional 
coactivator p300." Biochem Biophys Res Commun 377(4): 1304-1308. 
Sa, G. and T. Das (2008). "Anti cancer effects of curcumin: cycle of life and death." Cell 
Div 3: 14. 
Salvioli, S., E. Sikora, et al. (2007). "Curcumin in Cell Death Processes: A Challenge for 
CAM of Age-Related Pathologies." Evid Based Complement Alternat Med 4(2): 
181-190. 
Santibanez, J. F., M. Quintanilla, et al. (2000). "Genistein and curcumin block TGF-beta 
1-induced u-PA expression and migratory and invasive phenotype in mouse 
epidermal keratinocytes." Nutr Cancer 37(1): 49-54. 
Sasazaki, Y., B. B. Seedhom, et al. (2008). "Morphology of the bovine chondrocyte and 
of its cytoskeleton in isolation and in situ: are chondrocytes ubiquitously paired 
through the entire layer of articular cartilage?" Rheumatology (Oxford) 47(11): 
1641-1646. 
Schulze-Tanzil, G. (2009). "Activation and dedifferentiation of chondrocytes: 
implications in cartilage injury and repair." Ann Anat 191(4): 325-338. 
 82
Schulze-Tanzil, G., P. de Souza, et al. (2002). "Redifferentiation of dedifferentiated 
human chondrocytes in high-density cultures." Cell Tissue Res 308(3): 371-379. 
Schulze-Tanzil, G., A. Mobasheri, et al. (2004). "Loss of chondrogenic potential in 
dedifferentiated chondrocytes correlates with deficient Shc-Erk interaction and 
apoptosis." Osteoarthritis Cartilage 12(6): 448-458. 
Semenov, M. V., K. Tamai, et al. (2001). "Head inducer Dickkopf-1 is a ligand for Wnt 
coreceptor LRP6." Curr Biol 11(12): 951-961. 
Shakibaei, M., T. John, et al. (2007). "Suppression of NF-kappaB activation by curcumin 
leads to inhibition of expression of cyclo-oxygenase-2 and matrix 
metalloproteinase-9 in human articular chondrocytes: Implications for the 
treatment of osteoarthritis." Biochem Pharmacol 73(9): 1434-1445. 
Shakibaei, M., C. Seifarth, et al. (2006). "Igf-I extends the chondrogenic potential of 
human articular chondrocytes in vitro: molecular association between Sox9 and 
Erk1/2." Biochem Pharmacol 72(11): 1382-1395. 
Shogo Miyata, T. T., Katsuko Furukawa, Takashi Ushida (2005). "Influence of structure 
and composition on dynamic viscoelastic property of cartilaginous tissue: criteria 
for classification between hyaline cartilage and fibrocartilage based on 
mechanical function." JSME International Journal 48: 8. 
Simmons, P. J. and D. N. Haylock (1995). "Use of hematopoietic growth factors for in 
vitro expansion of precursor cell populations." Curr Opin Hematol 2(3): 189-195. 
Steadman, J. R., B. S. Miller, et al. (2003). "The microfracture technique in the treatment 
of full-thickness chondral lesions of the knee in National Football League 
players." J Knee Surg 16(2): 83-86. 
Suh, J. K., Z. Li, et al. (1995). "Dynamic behavior of a biphasic cartilage model under 
cyclic compressive loading." J Biomech 28(4): 357-364. 
Swiatek, W., I. C. Tsai, et al. (2004). "Regulation of casein kinase I epsilon activity by 
Wnt signaling." J Biol Chem 279(13): 13011-13017. 
Takahashi, T., T. Ogasawara, et al. (2005). "Synergistic effects of FGF-2 with insulin or 
IGF-I on the proliferation of human auricular chondrocytes." Cell Transplant 
14(9): 683-693. 
Tallheden, T., J. van der Lee, et al. (2005). "Human serum for culture of articular 
chondrocytes." Cell Transplant 14(7): 469-479. 
Thirion, S. and F. Berenbaum (2004). "Culture and phenotyping of chondrocytes in 
primary culture." Methods Mol Med 100: 1-14. 
Tufan, A. C., K. M. Daumer, et al. (2002). "AP-1 transcription factor complex is a target 
of signals from both WnT-7a and N-cadherin-dependent cell-cell adhesion 
complex during the regulation of limb mesenchymal chondrogenesis." Exp Cell 
Res 273(2): 197-203. 
Vivien, D., P. Galera, et al. (1990). "Differential effects of transforming growth factor-
beta and epidermal growth factor on the cell cycle of cultured rabbit articular 
chondrocytes." J Cell Physiol 143(3): 534-545. 
Von der Mark, K. (1986). "Differentiation, modulation and dedifferentiation of 
chondrocytes." Rheumatology  10: 272-315. 
Wang, Y., X. Chen, et al. (2006). "Growth inhibition of mesenchymal stem cells by 
aspirin: involvement of the WNT/beta-catenin signal pathway." Clin Exp 
Pharmacol Physiol 33(8): 696-701. 
 83
Watt, F. M. (1988). "Effect of seeding density on stability of the differentiated phenotype 
of pig articular chondrocytes in culture." J Cell Sci 89 ( Pt 3): 373-378. 
Wieland, H. A., M. Michaelis, et al. (2005). "Osteoarthritis - an untreatable disease?" Nat 
Rev Drug Discov 4(4): 331-344. 
Yang, X., L. Chen, et al. (2001). "TGF-beta/Smad3 signals repress chondrocyte 
hypertrophic differentiation and are required for maintaining articular cartilage." J 
Cell Biol 153(1): 35-46. 
Yang, X., D. P. Thomas, et al. (2006). "Curcumin inhibits platelet-derived growth factor-
stimulated vascular smooth muscle cell function and injury-induced neointima 
formation." Arterioscler Thromb Vasc Biol 26(1): 85-90. 
Yoon, D. M. and J. P. Fisher (2006). "Chondrocyte signaling and artificial matrices for 
articular cartilage engineering." Adv Exp Med Biol 585: 67-86. 
Yoon, Y. M., S. J. Kim, et al. (2002). "Maintenance of differentiated phenotype of 
articular chondrocytes by protein kinase C and extracellular signal-regulated 
protein kinase." J Biol Chem 277(10): 8412-8420. 
Zaucke, F., R. Dinser, et al. (2001). "Cartilage oligomeric matrix protein (COMP) and 
collagen IX are sensitive markers for the differentiation state of articular primary 
chondrocytes." Biochem J 358(Pt 1): 17-24. 
Zheng, M. H., C. Willers, et al. (2007). "Matrix-induced autologous chondrocyte 
implantation (MACI): biological and histological assessment." Tissue Eng 13(4): 
737-746. 
Zhu, M., M. Chen, et al. (2008). "Inhibition of beta-catenin signaling in articular 
chondrocytes results in articular cartilage destruction." Arthritis Rheum 58(7): 
2053-2064. 
Zhu, Y., A. Oganesian, et al. (1999). "Type IIA procollagen containing the cysteine-rich 
amino propeptide is deposited in the extracellular matrix of prechondrogenic 
tissue and binds to TGF-beta1 and BMP-2." J Cell Biol 144(5): 1069-1080. 
 
 
 
 
 84
